cached image

William J. Jagust, MD - Publications

Affiliations: 
Community Health & Human Development  University of California, Berkeley, Berkeley, CA 
Area:
Brain aging, dementia
Website:
http://bic.berkeley.edu/jagustlab/

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Jagust WJ, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216  0.596
2022 Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6  0.826
2021 Ciampa CJ, Parent JH, Lapoint MR, Swinnerton KN, Taylor MM, Tennant VR, Whitman AJ, Jagust WJ, Berry AS. Elevated Dopamine Synthesis as a Mechanism of Cognitive Resilience in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34718454 DOI: 10.1093/cercor/bhab379  0.784
2021 Yoon B, Guo T, Provost K, Korman D, Ward TJ, Landau SM, Jagust WJ. Abnormal tau in amyloid PET negative individuals. Neurobiology of Aging. 109: 125-134. PMID 34715443 DOI: 10.1016/j.neurobiolaging.2021.09.019  0.592
2021 Guo T, Landau SM, Jagust WJ. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults. Alzheimer's Research & Therapy. 13: 174. PMID 34654465 DOI: 10.1186/s13195-021-00913-5  0.506
2021 Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR, Jagust WJ, Petersen RC, Saykin AJ, Shaw LM, Trojanowski JQ, Weiner MW. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34647694 DOI: 10.1002/alz.12480  0.317
2021 Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, et al. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34581485 DOI: 10.1002/alz.12422  0.665
2021 Ziontz J, Adams JN, Harrison TM, Baker SL, Jagust WJ. Hippocampal connectivity with retrosplenial cortex is linked to neocortical tau accumulation and memory function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34531286 DOI: 10.1523/JNEUROSCI.0990-21.2021  0.334
2021 Risacher SL, West JD, Deardorff R, Gao S, Farlow MR, Brosch JR, Apostolova LG, McAllister TW, Wu YC, Jagust WJ, Landau SM, Weiner MW, Saykin AJ. Head injury is associated with tau deposition on PET in MCI and AD patients. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12230. PMID 34466653 DOI: 10.1002/dad2.12230  0.567
2021 Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau S, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain : a Journal of Neurology. PMID 34373896 DOI: 10.1093/brain/awab294  0.637
2021 Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ. Evaluation of [F]-JNJ-64326067-AAA tau PET tracer in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211031035. PMID 34259071 DOI: 10.1177/0271678X211031035  0.322
2021 Cassady KE, Adams JN, Chen X, Maass A, Harrison TM, Landau S, Baker S, Jagust W. Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34037210 DOI: 10.1093/cercor/bhab122  0.636
2021 Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, Bullich S, DeSanti S, Jagust WJ, Landau SM. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimer's Research & Therapy. 13: 99. PMID 33971965 DOI: 10.1186/s13195-021-00836-1  0.588
2021 Adams JN, Maass A, Berron D, Harrison TM, Baker SL, Thomas WP, Stanfill M, Jagust WJ. Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33731446 DOI: 10.1523/JNEUROSCI.2504-20.2021  0.307
2021 Jagust WJ, Landau SM. Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease. Neurology. PMID 33408147 DOI: 10.1212/WNL.0000000000011524  0.506
2020 Xia Y, Li L, Lockhart SN, Jagust WJ. Simultaneous Covariance Inference for Multimodal Integrative Analysis. Journal of the American Statistical Association. 115: 1279-1291. PMID 33867602 DOI: 10.1080/01621459.2019.1623040  0.565
2020 Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, Jagust WJ, Landau SM, La Joie R. Evaluation of a visual interpretation method for tau-PET with F-flortaucipir. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12133. PMID 33313377 DOI: 10.1002/dad2.12133  0.587
2020 La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, ... ... Jagust WJ, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. PMID 33262228 DOI: 10.1212/WNL.0000000000011270  0.333
2020 Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, ... ... Jagust WJ, et al. Diagnostic Accuracy of Amyloid versus FDG PET in Autopsy-Confirmed Dementia. Annals of Neurology. PMID 33219525 DOI: 10.1002/ana.25968  0.442
2020 Chen X, Cassady K, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33219003 DOI: 10.1523/JNEUROSCI.2111-20.2020  0.452
2020 Yoon B, Baker SL, Korman D, Tennant VR, Harrison TM, Landau S, Jagust WJ. Conscientiousness is associated with less amyloid deposition in cognitively normal aging. Psychology and Aging. 35: 993-999. PMID 33166168 DOI: 10.1037/pag0000582  0.622
2020 Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, Edwards L, Eser R, Gorno-Tempini ML, Jagust WJ, Janabi M, Kramer JH, Lesman-Segev OH, Mellinger T, Miller BL, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Brain : a Journal of Neurology. PMID 33141172 DOI: 10.1093/brain/awaa276  0.35
2020 Guo T, Korman D, Baker SL, Landau SM, Jagust WJ. Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biological Psychiatry. PMID 32919611 DOI: 10.1016/J.Biopsych.2020.06.029  0.653
2020 Winer JR, Mander BA, Kumar S, Reed M, Baker SL, Jagust WJ, Walker MP. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. Current Biology : Cb. PMID 32888482 DOI: 10.1016/J.Cub.2020.08.017  0.797
2020 Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cerebral Cortex (New York, N.Y. : 1991). PMID 32808011 DOI: 10.1093/Cercor/Bhaa184  0.474
2020 Guo T, Korman D, La Joie R, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM. Normalization of CSF pTau measurement by Aβ improves its performance as a biomarker of Alzheimer's disease. Alzheimer's Research & Therapy. 12: 97. PMID 32799929 DOI: 10.1186/S13195-020-00665-8  0.649
2020 Guo T, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM. Association of CSF Aβ, amyloid PET and cognition in cognitively unimpaired elderly adults. Neurology. PMID 32759202 DOI: 10.1212/Wnl.0000000000010596  0.652
2020 Han JW, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W, Mungas D, DeCarli C. Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory. Neurology. PMID 32732300 DOI: 10.1212/Wnl.0000000000010531  0.57
2020 Bejanin A, Tammewar G, Marx G, Cobigo Y, Iaccarino L, Kornak J, Staffaroni AM, Dickerson BC, Boeve BF, Knopman DS, Gorno-Tempini M, Miller BL, Jagust WJ, Boxer AL, Rosen HJ, et al. Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology. PMID 32591470 DOI: 10.1212/Wnl.0000000000009760  0.358
2020 Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, et al. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. Jama Neurology. PMID 32568366 DOI: 10.1001/Jamaneurol.2020.1760  0.332
2020 Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, et al. Relevance of biomarkers across different neurodegenerative. Alzheimer's Research & Therapy. 12: 56. PMID 32404143 DOI: 10.1186/S13195-020-00601-W  0.321
2020 Guo T, Landau SM, Jagust WJ. Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults. Neurology. PMID 32188766 DOI: 10.1212/WNL.0000000000009216  0.555
2020 Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline. Science Translational Medicine. 12. PMID 32161102 DOI: 10.1126/Scitranslmed.Aaz4069  0.452
2020 Giorgio J, Landau SM, Jagust WJ, Tino P, Kourtzi Z. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. Neuroimage. Clinical. 26: 102199. PMID 32106025 DOI: 10.1016/j.nicl.2020.102199  0.555
2020 Korecka M, Figurski MJ, Landau SM, Brylska M, Alexander J, Blennow K, Zetterberg H, Jagust WJ, Trojanowski JQ, Shaw LM. Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method. Clinical Chemistry. PMID 32087019 DOI: 10.1093/Clinchem/Hvaa012  0.636
2020 Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31915896 DOI: 10.1007/S00259-019-04669-X  0.412
2020 La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, ... ... Jagust WJ, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science Translational Medicine. 12. PMID 31894103 DOI: 10.1126/Scitranslmed.Aau5732  0.444
2019 Gallagher M, Okonkwo OC, Resnick SM, Jagust WJ, Benzinger TLS, Rapp PR. What are the threats to successful brain and cognitive aging? Neurobiology of Aging. 83: 130-134. PMID 31732016 DOI: 10.1016/J.Neurobiolaging.2019.04.016  0.403
2019 Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nature Communications. 10: 4900. PMID 31653847 DOI: 10.1038/S41467-019-12921-Z  0.364
2019 Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 8. PMID 31475904 DOI: 10.7554/Elife.49132  0.413
2019 Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. Sleep as a potential biomarker of tau and β-amyloid burden in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31209175 DOI: 10.1523/Jneurosci.0503-19.2019  0.807
2019 Leal SL, Ferguson LA, Harrison TM, Jagust WJ. Development of a mnemonic discrimination task using naturalistic stimuli with applications to aging and preclinical Alzheimer's disease. Learning & Memory (Cold Spring Harbor, N.Y.). 26: 219-228. PMID 31209116 DOI: 10.1101/lm.048967.118  0.327
2019 Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain : a Journal of Neurology. PMID 31199481 DOI: 10.1093/Brain/Awz154  0.464
2019 Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage. Clinical. 23: 101848. PMID 31077982 DOI: 10.1016/J.Nicl.2019.101848  0.401
2019 Baker SL, Harrison TM, Maaß A, La Joie R, Jagust W. Effect of off-target binding on F-Flortaucipir variability in healthy controls across the lifespan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877180 DOI: 10.2967/Jnumed.118.224113  0.351
2019 DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. Journal of Alzheimer's Disease : Jad. PMID 30775991 DOI: 10.3233/Jad-180965  0.57
2019 Berry AS, White RL, Furman DJ, Naskolnakorn JR, Shah VD, D'Esposito M, Jagust WJ. Dopaminergic mechanisms underlying normal variation in trait anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30737306 DOI: 10.1523/JNEUROSCI.2382-18.2019  0.612
2019 Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, ... ... Jagust W, et al. F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimer's Research & Therapy. 11: 13. PMID 30704514 DOI: 10.1186/S13195-019-0470-7  0.42
2019 Jagust W, Jack CR, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, et al. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 15: 153-157. PMID 30642435 DOI: 10.1016/J.Jalz.2018.11.002  0.387
2019 Xia Y, Li L, Lockhart SN, Jagust WJ. Simultaneous Covariance Inference for Multimodal Integrative Analysis Journal of the American Statistical Association. 115: 1279-1291. DOI: 10.1080/01621459.2019.1623040  0.556
2019 Guo T, Landau SM, Jagust WJ, Initiative ADN. Dt-01-03: Longitudinal Amyloid, Neurodegeneration And Cognition In Pre-Dementia Elderly Individuals With Different Atn Profiles Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.006  0.555
2019 Harrison TM, Becerra M, Winer JR, Baker SL, Grothe MJ, Jagust WJ. O4-12-02: Tau Pathology And Cognition Are Related To Basal Forebrain Degeneration In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4807  0.367
2019 Maass A, Harrison TM, Berron D, Adams JN, Joie RL, Baker SL, Düzel E, Jagust WJ. F4-02-02: Tau Pet Imaging In Aging: Contributions To Cognitive Decline And Neural Dysfunction Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4719  0.392
2019 Thijssen E, Rojas JC, Joie RL, Dage J, Airey DC, Proctor N, Chai X, Sims JR, Bourakova V, Strom A, Karydas AM, Wang P, Heuer HW, Kramer JH, Miller BL, ... ... Jagust WJ, et al. O2-05-04: Plasma Ptau181 Levels Reflect [18F]Av1451 Tau Pet Uptake Across The Tauopathy Spectrum Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4478  0.308
2019 Mander BA, Winer JR, Jagust WJ, Walker MP. F2-08-02: LOCAL SLOW WAVE MEASURES DURING NREM SLOW WAVE SLEEP ACCURATELY TRACK β-AMYLOID STATUS Alzheimer's & Dementia. 15: P528-P529. DOI: 10.1016/J.Jalz.2019.06.4445  0.777
2019 Baker SL, Joie RL, Liu C, Cobigo Y, Bourakova V, Harrison TM, Rabinovici GD, Jagust WJ. Ic-04-04: Iron, Neurodegeneration, Tau, And Amyloid In Patients With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4154  0.357
2019 Soleimani-Meigooni DN, Iaccarino L, La Joie R, Lesman-Segev OH, Bourakova V, Strom A, Edwards L, Baker SL, Janabi M, Eser R, Larsen E, Spina S, Seeley WW, Grinberg LT, Jagust WJ, et al. P2-439: [18 F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON-ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES Alzheimer's & Dementia. 15: P782-P782. DOI: 10.1016/J.Jalz.2019.06.2846  0.415
2019 Berry AS, Harrison TM, Whitman A, Swinnerton KN, Tennant VR, Fenton LE, Hsu M, Jagust WJ. P2-423: THE INFLUENCE OF DOPAMINE SYNTHESIS CAPACITY ON REWARD LEARNING AND INCIDENTAL ENCODING IN AGING Alzheimer's & Dementia. 15: P773-P774. DOI: 10.1016/j.jalz.2019.06.2830  0.508
2019 Harrison TM, Adams JN, Maass A, Du R, Baker SL, Jagust WJ. P2-353: Signal Coherence In The Hippocampus Is Related To Its Functional Isolation, Preclinical Alzheimer'S Disease Pathology And Memory In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2760  0.376
2019 Iaccarino L, Schonhaut DR, La Joie R, Ossenkoppele R, Bejanin A, Edwards L, Tammewar G, Pham JQ, Chaudhary K, Janabi M, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. P2-336: SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P720-P721. DOI: 10.1016/J.Jalz.2019.06.2743  0.349
2019 Protas H, Goradia DD, Ghisays V, Luo J, VanGilder PS, Thiyyagura P, Malek-Ahmadi M, Lee W, Chen Y, Devadas V, Bauer R, Landau SM, Weiner MW, Jagust WJ, Chen K, et al. Ic-P-173: Individual-Based Network Analysis: A Novel Approach To Investigate The Pathological Spread Of Phf Tau Using Graph Theory In Clinical And Preclinical Stages Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1023  0.594
2019 Giorgio J, Landau SM, Jagust WJ, Tino P, Kourtzi Z. PREDICTING FUTURE RATE OF COGNITIVE DECLINE DUE TO ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P228. DOI: 10.1016/j.jalz.2019.06.026  0.555
2018 Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ. Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease. Annals of Neurology. PMID 30597624 DOI: 10.1002/Ana.25406  0.427
2018 Berry AS, Jagust WJ, Hsu M. Age-related variability in decision-making: Insights from neurochemistry. Cognitive, Affective & Behavioral Neuroscience. PMID 30536205 DOI: 10.3758/s13415-018-00678-9  0.508
2018 Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, Jagust W. Biomarkers for tau pathology. Molecular and Cellular Neurosciences. PMID 30529601 DOI: 10.1016/J.Mcn.2018.12.001  0.36
2018 Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C, Jagust WJ, Jin LW, Klunk WE, et al. Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30347188 DOI: 10.1016/J.Jalz.2018.09.001  0.706
2018 Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321505 DOI: 10.1016/J.Jalz.2018.08.005  0.391
2018 He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ. Scan-time Corrections for 80-100 Minute Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging. Ieee Transactions On Medical Imaging. PMID 30235119 DOI: 10.1109/Tmi.2018.2870441  0.626
2018 Li L, Kang J, Lockhart SN, Adams J, Jagust WJ. Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data. Ieee Transactions On Medical Imaging. PMID 30028695 DOI: 10.1109/Tmi.2018.2857221  0.635
2018 Adams JN, Lockhart SN, Li L, Jagust WJ. Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults. Cerebral Cortex (New York, N.Y. : 1991). PMID 29912295 DOI: 10.1093/Cercor/Bhy078  0.666
2018 Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, et al. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging. Jama Neurology. PMID 29799981 DOI: 10.1001/Jamaneurol.2018.0975  0.579
2018 Berry AS, Shah VD, Jagust WJ. The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults. Journal of Cognitive Neuroscience. 1-15. PMID 29791298 DOI: 10.1162/jocn_a_01286  0.508
2018 Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29686045 DOI: 10.1523/Jneurosci.0485-18.2018  0.709
2018 Harrison TM, Maass A, Baker SL, Jagust WJ. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance. Neurobiology of Aging. 67: 162-170. PMID 29665578 DOI: 10.1016/J.Neurobiolaging.2018.03.024  0.381
2018 Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 535-562. PMID 29653606 DOI: 10.1016/J.Jalz.2018.02.018  0.444
2018 Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009  0.632
2018 Landau SM, Horng A, Jagust WJ. Memory decline accompanies subthreshold amyloid accumulation. Neurology. PMID 29572282 DOI: 10.1212/WNL.0000000000005354  0.555
2018 Arnemann KL, Stöber F, Narayan S, Rabinovici GD, Jagust WJ. Metabolic brain networks in aging and preclinical Alzheimer's disease. Neuroimage. Clinical. 17: 987-999. PMID 29527500 DOI: 10.1016/j.nicl.2017.12.037  0.401
2018 Sescousse G, Ligneul R, van Holst RJ, Janssen LK, de Boer F, Janssen M, Berry AS, Jagust WJ, Cools R. Spontaneous eye blink rate and dopamine synthesis capacity: Preliminary evidence for an absence of positive correlation. The European Journal of Neuroscience. PMID 29514419 DOI: 10.1111/Ejn.13895  0.521
2018 Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, ... ... Jagust WJ, et al. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. Jama Neurology. PMID 29309493 DOI: 10.1001/Jamaneurol.2017.4309  0.304
2018 Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, ... ... Jagust WJ, et al. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage. Clinical. 17: 452-464. PMID 29159058 DOI: 10.1016/J.Nicl.2017.09.016  0.682
2018 Leal SL, Jagust WJ. P2-083: The Influence Of Aging And Tau Deposition On Memory Consolidation Using A Novel Ecologically Valid Memory Task Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.768  0.307
2018 Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. O4-09-04: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2960  0.392
2018 Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. Ic-P-205: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And Those With Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2272  0.395
2018 Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ, Adams JN. F1-04-04: Effects Of Tau And Amyloid Deposition Measured By Pet On Domain-Specific Memory Function In Old Age Alzheimers & Dementia. 14: 87. DOI: 10.1016/J.Jalz.2018.06.2167  0.379
2018 Sonni I, Lesman-Segev OH, Maass A, Baker SL, Korman D, Rabinovici GD, Jagust WJ. P2-373: Evaluation Of Visual Interpretation Methods For Tau Pet Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1064  0.305
2018 Sescousse G, Ligneul R, van Holst R, Janssen L, de Boer F, Janssen M, Berry A, Jagust W, Cools R. F180. Spontaneous Eye Blink Rate: A Good Proxy for Dopamine? Biological Psychiatry. 83: S308-S309. DOI: 10.1016/J.Biopsych.2018.02.794  0.491
2018 van Holst R, Sescousse G, Timmeren T, Ouden Hd, Berry A, Jagust W, Cools R. S258. Dorsal, but Not Ventral Striatal Dopamine Mediates the Effect of Gambling Disorder on Compulsivity During Reversal Learning Biological Psychiatry. 83: S448-S449. DOI: 10.1016/j.biopsych.2018.02.1150  0.479
2017 La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, ... ... Jagust WJ, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. PMID 29282337 DOI: 10.1212/Wnl.0000000000004860  0.35
2017 Helfrich RF, Mander BA, Jagust WJ, Knight RT, Walker MP. Old Brains Come Uncoupled in Sleep: Slow Wave-Spindle Synchrony, Brain Atrophy, and Forgetting. Neuron. PMID 29249289 DOI: 10.1016/J.Neuron.2017.11.020  0.793
2017 Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease. Jama Neurology. PMID 29228071 DOI: 10.1001/Jamaneurol.2017.3713  0.395
2017 Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ. Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192126 DOI: 10.1523/Jneurosci.2028-17.2017  0.699
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Jagust WJ, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.656
2017 Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, Ryu YH, Choi JY, Rabinovici GD, Kim HJ, Moon SH, Jang H, Lee JS, Jagust WJ, Na DL, et al. Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29143870 DOI: 10.1007/S00259-017-3876-0  0.41
2017 Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data in Brief. 15: 648-657. PMID 29124088 DOI: 10.1016/J.Dib.2017.10.024  0.36
2017 Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nature Communications. 8: 1214. PMID 29089479 DOI: 10.1038/S41467-017-01150-X  0.648
2017 Mander BA, Zhu AH, Lindquist JR, Villeneuve S, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust W, Walker MP. White matter structure in older adults moderates the benefit of sleep spindles on motor memory consolidation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29084867 DOI: 10.1523/Jneurosci.3033-16.2017  0.783
2017 Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, ... Jagust WJ, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain : a Journal of Neurology. PMID 29053874 DOI: 10.1093/Brain/Awx243  0.487
2017 Vogel JW, Varga Doležalová M, La Joie R, Marks SM, Schwimmer HD, Landau SM, Jagust WJ. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly. Neurology. PMID 28986416 DOI: 10.1212/WNL.0000000000004627  0.555
2017 Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, ... ... Jagust WJ, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/Ana.25060  0.36
2017 Berry AS, Shah VD, Furman DJ, White RL, Baker SL, O'Neil JP, Janabi M, D'Esposito M, Jagust WJ. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but not Dopamine Release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816243 DOI: 10.1038/Npp.2017.180  0.604
2017 van Holst RJ, Sescousse G, Janssen LK, Janssen M, Berry AS, Jagust WJ, Cools R. Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction. Biological Psychiatry. PMID 28728675 DOI: 10.1016/J.Biopsych.2017.06.010  0.505
2017 Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. PMID 28587897 DOI: 10.1016/J.Neuroimage.2017.05.058  0.785
2017 Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Frontiers in Neuroscience. 11: 281. PMID 28567001 DOI: 10.3389/Fnins.2017.00281  0.555
2017 Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Berlo VV, Jin LW, Chui HC, Coppola G, Ringman JM. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 28550247 DOI: 10.3233/JAD-161203  0.578
2017 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28342697 DOI: 10.1016/J.Jalz.2016.11.007  0.362
2017 Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals. Brain : a Journal of Neurology. PMID 28334939 DOI: 10.1093/Brain/Awx046  0.665
2017 Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. Jama Neurology. PMID 28319241 DOI: 10.1001/Jamaneurol.2016.5349  0.764
2017 Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Amyloid and Tau PET Demonstrate Region-Specific Associations in Normal Older People. Neuroimage. PMID 28232190 DOI: 10.1016/J.Neuroimage.2017.02.051  0.674
2017 Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and β-amyloid are associated with medial temporal lobe structure, function and memory encoding in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28213439 DOI: 10.1523/Jneurosci.3769-16.2017  0.685
2017 Lockhart SN, Ayakta N, Winer JR, La Joie R, Rabinovici GD, Jagust WJ. Elevated (18)F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology. PMID 28188303 DOI: 10.1212/Wnl.0000000000003724  0.665
2017 Leal SL, Landau SM, Bell RK, Jagust WJ. Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife. 6. PMID 28177283 DOI: 10.7554/eLife.22978  0.659
2017 Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust WJ, Murray ME, et al. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. PMID 28130473 DOI: 10.1212/Wnl.0000000000003636  0.367
2017 Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O'Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD. Regional correlations between [(11)C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage. Clinical. 13: 130-137. PMID 27981028 DOI: 10.1016/J.Nicl.2016.11.008  0.548
2017 Leal SL, Landau SM, Bell RK, Jagust WJ. Author response: Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline Elife. DOI: 10.7554/Elife.22978.012  0.621
2017 Harrison TM, Lockhart SN, Baker SL, Jagust WJ. THE ROLE OF β-AMYLOID IN SUPERAGERS WITH SUPERIOR MEMORY PERFORMANCE AND PRESERVED BRAIN MORPHOMETRY Alzheimer's & Dementia. 13: P1463-P1464. DOI: 10.1016/J.Jalz.2017.07.532  0.622
2017 Jagust WJ, Landau SM. PET IMAGING THROUGH THE COURSE OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P878. DOI: 10.1016/j.jalz.2017.07.263  0.555
2017 Lockhart SN, Adams JN, Baker SL, Kang J, Li L, Jagust WJ. EFFECTS OF TAU DEPOSITION ON CEREBRAL GLUCOSE METABOLISM IN NORMAL OLDER ADULTS VARY BY AMYLOID LEVEL Alzheimer's & Dementia. 13: P202. DOI: 10.1016/J.Jalz.2017.07.066  0.625
2017 La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-01-01]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1-P1. DOI: 10.1016/J.Jalz.2017.06.2621  0.37
2017 Lockhart SN, Maass A, Marks SM, Baker SL, Jagust WJ. ASSOCIATIONS BETWEEN HIPPOCAMPAL AV-1451 DEPOSITION AND LIMBIC WHITE MATTER INTEGRITY IN NORMAL AGING Alzheimer's & Dementia. 13: P140. DOI: 10.1016/J.Jalz.2017.06.2565  0.599
2017 La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Karydas A, Jerome G, O'Neil JP, Pham J, Visani A, Rosen H, Boxer A, Miller BL, Jagust WJ, et al. AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? Alzheimer's & Dementia. 13: P137-P138. DOI: 10.1016/J.Jalz.2017.06.2561  0.301
2017 Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini M, Miller ZA, Rosen HJ, Miller BL, ... Jagust WJ, et al. [IC-P-176]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P131-P131. DOI: 10.1016/J.Jalz.2017.06.2551  0.426
2017 Maass A, Lockhart SN, Mellinger TJ, Bell RK, Baker SL, Jagust WJ. [IC-P-124]: MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING Alzheimer's & Dementia. 13: P94-P95. DOI: 10.1016/J.Jalz.2017.06.2398  0.626
2017 La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-P-059]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P48-P49. DOI: 10.1016/J.Jalz.2017.06.2332  0.439
2017 Reiman EM, Kuang X, Luo J, Chen Y, Thiyyagura P, Bauer R, Lee W, Protas H, Goradia DD, Aisen PS, Johnson K, Langbaum JB, Sperling RA, Tariot P, Jagust WJ, et al. [IC-P-041]: SAMPLE SIZES FOR 24-MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS Alzheimer's & Dementia. 13: P36-P37. DOI: 10.1016/J.Jalz.2017.06.2313  0.379
2017 Landau SM, Jagust WJ. [IC-P-013]: AMYLOID ACCUMULATION WITHIN THE NEGATIVE RANGE IS LINKED TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER INDIVIDUALS Alzheimer's & Dementia. 13: P17-P18. DOI: 10.1016/j.jalz.2017.06.2285  0.555
2017 Jang YK, Lyoo CH, Rabinovici GD, Oh SJ, Cho H, Oh M, Ryu YH, Park S, Kim HJ, Moon SH, Jagust WJ, Na DL, Kim JS, Seo SW. [P4-212]: HEAD-TO-HEAD COMPARISON OF [18 F] AV-1451 AND [18 F] THK5351 FOR TAU IMAGING IN ALZHEIMER's DISEASE AND FRONTOTEMPORAL DEMENTIA Alzheimer's & Dementia. 13: P1347-P1348. DOI: 10.1016/J.Jalz.2017.06.2080  0.37
2017 Insel P, Ossenkoppele R, Gessert D, Jagust WJ, Landau SM, Hansson O, Weiner M, Mattsson N. Emerging Amyloid Pathology Alzheimers & Dementia. 13: 1340. DOI: 10.1016/J.Jalz.2017.06.2064  0.555
2017 Baker SL, Lockhart SN, Maass A, Jagust WJ. [P4-052]: PARTIAL VOLUME EFFECTS AND MEDIAL TEMPORAL LOBE TAU QUANTITATION WITH PET Alzheimer's & Dementia. 13: P1277-P1277. DOI: 10.1016/J.Jalz.2017.06.1917  0.631
2017 Goradia DD, Chen K, Chen Y, Snyder N, Harvey D, Landau SM, Jagust WJ, Weiner M, Reiman EM. [P3–032]: Ssri Use Associated With Reduced Amyloid Burden In Persons With Combat‐Related Ptsd: Preliminary Findings From Adni‐Dod Alzheimers & Dementia. 13: 942. DOI: 10.1016/J.Jalz.2017.06.1845  0.555
2017 van Holst R, Sescousse G, Janssen L, Janssen M, Berry A, Jagust W, Cools R. 195. Increased Dopamine Synthesis Capacity in Gambling Addiction Predicts Drug-Induced Enhances in Reward Learning Biological Psychiatry. 81: S81. DOI: 10.1016/J.Biopsych.2017.02.208  0.471
2016 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, et al. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27931796 DOI: 10.1016/J.Jalz.2016.10.006  0.381
2016 Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ. Aging affects dopaminergic neural mechanisms of cognitive flexibility. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27807030 DOI: 10.1523/Jneurosci.0626-16.2016  0.567
2016 Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Annals of Clinical and Translational Neurology. 3: 740-751. PMID 27752510 DOI: 10.1002/Acn3.330  0.396
2016 Babiloni C, Del Percio C, Caroli A, Salvatore E, Nicolai E, Marzano N, Lizio R, Cavedo E, Landau S, Chen K, Jagust W, Reiman E, Tedeschi G, Montella P, De Stefano M, et al. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study. Neurobiology of Aging. 48: 122-134. PMID 27668356 DOI: 10.1016/j.neurobiolaging.2016.08.021  0.592
2016 Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference tissue-based kinetic evaluation of 18F-AV-1451 in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587706 DOI: 10.2967/Jnumed.116.175273  0.688
2016 Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust WJ, Chui HC. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. Jama Neurology. PMID 27532692 DOI: 10.1001/Jamaneurol.2016.1924  0.486
2016 Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno-Tempini ML, D Rabinovici G, Perani D. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Human Brain Mapping. PMID 27412866 DOI: 10.1002/Hbm.23305  0.358
2016 Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. PMID 27371494 DOI: 10.1212/Wnl.0000000000002923  0.418
2016 Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/Brain/Aww159  0.422
2016 Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. Plos One. 11: e0158460. PMID 27355840 DOI: 10.1371/Journal.Pone.0158460  0.684
2016 Mander BA, Winer J, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends in Neurosciences. PMID 27325209 DOI: 10.1016/J.Tins.2016.05.002  0.804
2016 Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain : a Journal of Neurology. PMID 27190008 DOI: 10.1093/Brain/Aww108  0.737
2016 Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology. Neurology. PMID 27164667 DOI: 10.1212/Wnl.0000000000002683  0.365
2016 Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiology of Aging. 40: 173-80. PMID 26973117 DOI: 10.1016/J.Neurobiolaging.2016.01.133  0.581
2016 Landau SM, Horng A, Fero A, Jagust WJ. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology. PMID 26968515 DOI: 10.1212/WNL.0000000000002576  0.555
2016 Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, ... ... Jagust WJ, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26962052 DOI: 10.1093/Brain/Aww027  0.705
2016 Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 89: 971-82. PMID 26938442 DOI: 10.1016/J.Neuron.2016.01.028  0.711
2016 Jung NY, Han CE, Kim HJ, Yoo SW, Kim HJ, Kim EJ, Na DL, Lockhart SN, Jagust WJ, Seong JK, Seo SW. Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 26836179 DOI: 10.3233/Jad-150841  0.641
2016 Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nature Reviews. Neurology. PMID 26782335 DOI: 10.1038/Nrneurol.2015.251  0.413
2016 Winer JR, Mander BA, Lockhart SN, Schöll M, Saletin JM, Lu BS, Ancoli-Israel S, Jagust WJ, Walker MP. O4-09-01: An Nrem Sleep Signature of Human in Vivo TAU Burden Alzheimer's & Dementia. 12: P353-P353. DOI: 10.1016/J.Jalz.2016.06.654  0.771
2016 Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. O3-08-04: Tau Covariance Patterns in Alzheimer's Disease Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P305-P306. DOI: 10.1016/J.Jalz.2016.06.552  0.338
2016 Risacher SL, Deters K, Schwarz AJ, Shcherbinin S, West JD, Jagust WJ, Jack CR, Weiner MW, Saykin AJ. Relationship Between [18F]Av-1451 Binding And Antecedent Amyloid Deposition, Glucose Hypometabolism And Atrophy Measures: Preliminary Analysis In The Adni Cohort Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.237  0.32
2016 Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. IC-P-193: Examining Amyloid and TAU Inter-Regional PET Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P139-P140. DOI: 10.1016/J.Jalz.2016.06.224  0.668
2016 Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. IC-P-192: TAU Covariance Patterns in ad Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P138-P139. DOI: 10.1016/J.Jalz.2016.06.223  0.327
2016 Mellinger TJ, Swinnerton KN, Bell RK, Landau SM, Jagust WJ. P3-270: Current Cognitive Engagement is Associated with Reduced Glucose Hypometabolism in Cognitively Normal Elderly Alzheimer's & Dementia. 12: P936-P937. DOI: 10.1016/j.jalz.2016.06.1933  0.555
2016 Arenaza-Urquijo EM, Landau SM, Bell RK, Lockhart SN, Mellinger TJ, Baker SL, Chetelat G, Jagust WJ. IC-P-131: Normal Cognition Despite Very High Risk for Alzheimer’s Disease: Neuroimaging and Neuropsychological Insights Into Resilient Brain Aging Alzheimer's & Dementia. 12: P98-P99. DOI: 10.1016/J.Jalz.2016.06.161  0.735
2016 Mander BA, Winer JR, Marks S, Vogel JW, Lu BS, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. P2-162: NREM Slow Wave Activity <1HZ as a Biomarker and Long-Term Predictor of B-Amyloid Burden in Older Adults Alzheimer's & Dementia. 12: P676-P677. DOI: 10.1016/J.Jalz.2016.06.1329  0.781
2016 Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart S, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. P1-318: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P545-P547. DOI: 10.1016/J.Jalz.2016.06.1069  0.669
2016 Schreiber S, Landau SM, Lockhart S, Bejanin A, Horng A, Schreiber F, Jagust WJ. P1-295: SNAP: Alzheimer's Disease Plus Overlapping Non-Ad Patterns in The Aging Brain? Alzheimer's & Dementia. 12: P533-P534. DOI: 10.1016/J.Jalz.2016.06.1045  0.753
2016 Snyder N, Chen K, Luo J, Thiyyagura P, Devadas V, Chen Y, Bauer R, Sheline YI, Jagust WJ, Neylan T, Landau SM, Weiner MW, Reiman EM. P1-292: Lower Frontal Amyloid Burden in Antidepressant Users: Preliminary Findings From Persons With and Without Post-Traumatic Stress Disorder in The ADNI DOD Study Alzheimer's & Dementia. 12: P532-P533. DOI: 10.1016/J.Jalz.2016.06.1042  0.555
2016 Risacher SL, Deters K, Schwarz AJ, Shcherbinin S, West JD, Jagust WJ, Jack CR, Weiner MW, Saykin AJ. Association Of [18F]Av-1451 Tau Markers With Cognitive And Neurodegeneration Measures: Preliminary Analysis In The Adni Cohort Alzheimers & Dementia. 12: 512. DOI: 10.1016/J.Jalz.2016.06.1010  0.376
2016 Rabinovici GD, Ayakta N, Rosen HJ, Seo SW, O'Neil JP, Janabi M, Ossenkoppele R, Lehmann M, Reed B, Olichney J, Boxer AL, Jin L, Huang E, Gorno-Tempini M, DeCarli C, ... ... Jagust WJ, et al. P1-253: Diagnostic Accuracy of Amyloid- Versus Fdg-Pet in Autopsy-Confirmed Dementia Alzheimer's & Dementia. 12: P506-P507. DOI: 10.1016/J.Jalz.2016.06.1002  0.543
2016 Ayakta N, Seeley WW, Grinberg LT, Lockhart SN, O'Neil JP, Ossenkoppele R, Reed B, Olichney J, Boxer AL, Miller B, Borys E, Jin L, Huang E, DeCarli C, Jagust WJ, et al. IC-P-055: Centiloid Thresholds for Amyloid Positivity Derived from Autopsy-Proven Cases Alzheimer's & Dementia. 12: P45-P46. DOI: 10.1016/J.Jalz.2016.06.085  0.656
2016 Horng A, Jagust WJ, Landau SM. IC-P-009: Effects of Baseline Regional Amyloid Deposition Patterns on Subsequent Accumulation Alzheimer's & Dementia. 12: P18-P19. DOI: 10.1016/j.jalz.2016.06.019  0.555
2015 Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, Teng E, Gylys K, Cole G, Saykin AJ, Shaw LM, Trojanowski JQ, Jagust WJ, Weiner MW, Apostolova LG, et al. Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurology. Genetics. 1: e22. PMID 27066559 DOI: 10.1212/Nxg.0000000000000022  0.347
2015 Smith CT, Wallace DL, Dang LC, Aarts E, Jagust WJ, D'Esposito M, Boettiger CA. Modulation of Impulsivity and Reward Sensitivity in Intertemporal Choice by Striatal and Midbrain Dopamine Synthesis in Healthy Adults. Journal of Neurophysiology. jn.00261.2015. PMID 26683066 DOI: 10.1152/Jn.00261.2015  0.481
2015 Tosun D, Schuff N, Jagust W, Weiner MW. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Neuro-Degenerative Diseases. PMID 26560336 DOI: 10.1159/000439257  0.393
2015 Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain : a Journal of Neurology. PMID 26419799 DOI: 10.1093/Brain/Awv278  0.555
2015 Schreiber S, Landau SM, Fero A, Schreiber F, Jagust WJ. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. Jama Neurology. PMID 26280102 DOI: 10.1001/jamaneurol.2015.1633  0.555
2015 Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, ... ... Jagust WJ, et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain : a Journal of Neurology. PMID 26268530 DOI: 10.1093/Brain/Awv231  0.453
2015 Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust WJ, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Human Brain Mapping. PMID 26260856 DOI: 10.1002/Hbm.22927  0.764
2015 Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, Coppola G, Miller BL, Jagust WJ, Gorno-Tempini ML, Seeley WW, Rabinovici GD. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants. Neurobiology of Aging. 36: 2678-86. PMID 26242705 DOI: 10.1016/J.Neurobiolaging.2015.06.029  0.353
2015 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 865-84. PMID 26194320 DOI: 10.1016/J.Jalz.2015.04.005  0.499
2015 Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 757-71. PMID 26194311 DOI: 10.1016/J.Jalz.2015.05.001  0.637
2015 Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, Joie RL, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, ... ... Jagust WJ, et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain : a Journal of Neurology. 138: 2732-49. PMID 26141491 DOI: 10.1093/Brain/Awv191  0.768
2015 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: e1-e120. PMID 26073027 DOI: 10.1016/J.Jalz.2014.11.001  0.457
2015 Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, ... Jagust WJ, et al. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 1-8. PMID 26040468 DOI: 10.1080/13554794.2015.1046458  0.43
2015 Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nature Neuroscience. 18: 1051-7. PMID 26030850 DOI: 10.1038/Nn.4035  0.807
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669  0.66
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Jagust WJ, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.605
2015 Wallace DL, Aarts E, d'Oleire Uquillas F, Dang LC, Greer SM, Jagust WJ, D'Esposito M. Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of "unhealthy" foods. Appetite. 92: 74-80. PMID 25963102 DOI: 10.1016/J.Appet.2015.05.004  0.444
2015 Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR, Beckett LA, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, et al. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25960448 DOI: 10.1016/J.Jalz.2015.03.003  0.405
2015 Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, ... ... Jagust W, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain : a Journal of Neurology. 138: 2020-33. PMID 25953778 DOI: 10.1093/Brain/Awv112  0.778
2015 Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. Jama Neurology. 72: 571-81. PMID 25822737 DOI: 10.1001/Jamaneurol.2014.4829  0.65
2015 Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. Jama Neurology. 72: 554-60. PMID 25775167 DOI: 10.1001/Jamaneurol.2014.4530  0.392
2015 Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 567-74. PMID 25745095 DOI: 10.2967/Jnumed.114.148981  0.637
2015 Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, ... Jagust WJ, et al. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 560-6. PMID 25745091 DOI: 10.2967/Jnumed.114.149732  0.61
2015 Sha SJ, Ghosh PM, Lee SE, Corbetta-Rastelli C, Jagust WJ, Kornak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Gorno-Tempini M, Kramer J, Miller BL, et al. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's Research & Therapy. 7: 8. PMID 25733984 DOI: 10.1186/S13195-014-0093-Y  0.303
2015 Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 84: 729-37. PMID 25609767 DOI: 10.1212/Wnl.0000000000001231  0.498
2015 Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Brain : a Journal of Neurology. 138: 772-83. PMID 25541191 DOI: 10.1093/Brain/Awu367  0.662
2015 Dowling NM, Johnson SC, Gleason CE, Jagust WJ. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 105: 357-68. PMID 25450107 DOI: 10.1016/j.neuroimage.2014.10.050  0.475
2015 Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Annals of Neurology. 77: 338-42. PMID 25448043 DOI: 10.1002/Ana.24321  0.424
2015 Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1-15.e1-4. PMID 25443857 DOI: 10.1016/J.Jalz.2014.07.003  0.349
2015 Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Reiman EM, Jagust WJ, Frisoni GB. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Alzheimer Disease and Associated Disorders. 29: 101-9. PMID 25437302 DOI: 10.1097/WAD.0000000000000071  0.602
2015 Vogel JW, Doležalová MV, Joie RL, Marks S, Fero A, Landau SM, Schwimmer H, Schreiber S, Jagust WJ. Brain and cognitive correlates of subjective cognitive decline differ between healthy elderly with and without β-amyloid pathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.451  0.555
2015 Schöll M, Vogel JW, Schonhaut D, Lockhart S, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. Cognitive decline in healthy elderly is related to temporal lobe tau but not to cortical β-amyloid: An 18F-AV1451 and 11C-PiB PET study Alzheimers & Dementia. 11: 313-314. DOI: 10.1016/J.Jalz.2015.07.448  0.677
2015 Seo SW, Ayakta N, Lehmann M, Miller BL, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD. O4-08-01: Regional correlations between PiB-PET and postmortem burden of amyloid species Alzheimer's & Dementia. 11: P285-P286. DOI: 10.1016/J.Jalz.2015.07.387  0.328
2015 Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, Foroud TM, Aisen PS, Petersen RC, Toga AW, Green RC, Jagust WJ, Weiner MW, Saykin AJ. Gwas of longitudinal amyloid PET identifies IL1RAP as a new potential Alzheimer's disease target Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.369  0.402
2015 Ossenkoppele R, Pijnenburg YA, Perry D, Cohn-Sheehy B, Scheltens NM, Vogel JW, Kramer J, van der Vlies A, La Joie R, Rosen H, van der Flier WM, Grinberg L, Rozemuller A, Huang E, van Berckel BN, ... ... Jagust WJ, et al. F2-03-03: Characterization of the behavioral and dysexecutive variants of Alzheimer's disease Alzheimer's & Dementia. 11: P168-P168. DOI: 10.1016/J.Jalz.2015.07.118  0.742
2015 Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Ossenkoppele R. F2-03-01: Tau and amyloid neuroimaging of ad phenotypes Alzheimer's & Dementia. 11: P167-P167. DOI: 10.1016/J.Jalz.2015.07.116  0.658
2015 Walker MP, Mander BA, Marks S, Rao V, Lu BS, Saletin J, Ancoli-Israel S, Jagust WJ. F2-02-03: Beta-amyloid deposition in the human brain disrupts nrem slow wave sleep and associated hippocampus-dependent long-term memory Alzheimer's & Dementia. 11: P166-P166. DOI: 10.1016/J.Jalz.2015.07.114  0.791
2015 Lockhart S, Schöll M, Schonhaut D, Ossenkoppele R, Vogel JW, Baker S, Schwimmer H, Rabinovici GD, Jagust WJ. Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.191  0.657
2015 Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. IC-P-161: Tau PET with [18 F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P107-P109. DOI: 10.1016/J.Jalz.2015.06.184  0.656
2015 Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-157: Associations of [18 F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P105-P106. DOI: 10.1016/J.Jalz.2015.06.180  0.687
2015 Villeneuve S, St. Amant H, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. P3-145: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P681-P682. DOI: 10.1016/J.Jalz.2015.06.1013  0.462
2015 Landau SM, Fero A, Jagust WJ. IC-P-058: Amyloid negativity in clinically diagnosed ADNI Alzheimer's disease and MCI patients Alzheimer's & Dementia. 11: P44-P44. DOI: 10.1016/j.jalz.2015.06.079  0.555
2015 Nho K, Kim S, Risacher SL, Foroud TM, Aisen PS, Petersen RC, Jagust WJ, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, Greicius MD, Saykin AJ. IC-P-042: Influence of rare reelin variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer's disease Alzheimer's & Dementia. 11: P36-P36. DOI: 10.1016/J.Jalz.2015.06.062  0.371
2015 Risacher SL, Kim S, Nho K, Jack CR, Jagust WJ, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.057  0.316
2015 Ossenkoppele R, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. IC-02-02: Distinct [18 F]AV1451 retention patterns in clinical variants of Alzheimer's disease Alzheimer's & Dementia. 11: P5-P6. DOI: 10.1016/J.Jalz.2015.06.008  0.63
2015 Schöll M, Schonhaut D, Lockhart S, Vogel JW, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. In vivo braak staging using 18F-AV1451 Tau PET imaging Alzheimers & Dementia. 11: 4. DOI: 10.1016/J.Jalz.2015.06.006  0.619
2015 Villeneuve S, Amant HS, Vogel JW, Marks S, Wirth M, DeCarli C, Jagust WJ. IC-01-01: Are low levels of PiB-PET signal clinically significant? Alzheimer's & Dementia. 11: P1-P1. DOI: 10.1016/J.Jalz.2015.06.002  0.451
2015 Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Alzheimer's and Dementia. 11: 757-771. DOI: 10.1016/j.jalz.2015.05.001  0.506
2014 Schicktanz S, Schweda M, Ballenger JF, Fox PJ, Halpern J, Kramer JH, Micco G, Post SG, Thompson C, Knight RT, Jagust WJ. Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction. Frontiers in Human Neuroscience. 8: 921. PMID 25477802 DOI: 10.3389/Fnhum.2014.00921  0.336
2014 Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25457431 DOI: 10.1016/J.Jalz.2014.09.004  0.624
2014 Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cerebral Cortex (New York, N.Y. : 1991). PMID 25405944 DOI: 10.1093/Cercor/Bhu259  0.387
2014 Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Annals of Clinical and Translational Neurology. 1: 534-43. PMID 25356425 DOI: 10.1002/Acn3.81  0.656
2014 Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Neural compensation in older people with brain amyloid-β deposition. Nature Neuroscience. 17: 1316-8. PMID 25217827 DOI: 10.1038/Nn.3806  0.717
2014 Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ. Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8612-7. PMID 24948815 DOI: 10.1523/Jneurosci.4612-13.2014  0.43
2014 Weiner MW, Veitch DP, Hayes J, Neylan T, Grafman J, Aisen PS, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Shaw LM, Saykin AJ, Green RC, Harvey D, Toga AW, et al. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S226-35. PMID 24924673 DOI: 10.1016/J.Jalz.2014.04.005  0.395
2014 Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust WJ. Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 83: 40-7. PMID 24907234 DOI: 10.1212/Wnl.0000000000000550  0.509
2014 Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage. Clinical. 4: 508-16. PMID 24818077 DOI: 10.1016/J.Nicl.2014.03.005  0.442
2014 Wallace DL, Aarts E, Dang LC, Greer SM, Jagust WJ, D'Esposito M. Dorsal striatal dopamine, food preference and health perception in humans. Plos One. 9: e96319. PMID 24806534 DOI: 10.1371/Journal.Pone.0096319  0.456
2014 Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults. Neurobiology of Aging. 35: 1873-82. PMID 24656834 DOI: 10.1016/J.Neurobiolaging.2014.02.015  0.428
2014 Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1398-407. PMID 24647577 DOI: 10.1007/S00259-014-2753-3  0.644
2014 Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain : a Journal of Neurology. 137: 1550-61. PMID 24625697 DOI: 10.1093/Brain/Awu043  0.401
2014 Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathologica Communications. 2: 26. PMID 24602322 DOI: 10.1186/2051-5960-2-26  0.428
2014 Aarts E, Wallace DL, Dang LC, Jagust WJ, Cools R, D'Esposito M. Dopamine and the cognitive downside of a promised bonus. Psychological Science. 25: 1003-9. PMID 24525265 DOI: 10.1177/0956797613517240  0.511
2014 Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. Plos One. 9: e87747. PMID 24498184 DOI: 10.1371/Journal.Pone.0087747  0.375
2014 Villeneuve S, Reed BR, Wirth M, Haase CM, Madison CM, Ayakta N, Mack W, Mungas D, Chui HC, DeCarli C, Weiner MW, Jagust WJ. Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology. 82: 761-7. PMID 24489134 DOI: 10.1212/Wnl.0000000000000170  0.516
2014 Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. Jama Neurology. 71: 195-200. PMID 24378418 DOI: 10.1001/Jamaneurol.2013.5390  0.498
2014 Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, ... ... Jagust WJ, et al. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. 82: 230-8. PMID 24353340 DOI: 10.1212/Wnl.0000000000000032  0.385
2014 Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 266-73. PMID 23965289 DOI: 10.1136/Jnnp-2013-305858  0.42
2014 Mander BA, Rao V, Lu B, Saletin JM, Ancoli-Israel S, Jagust WJ, Walker MP. Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. Cerebral Cortex (New York, N.Y. : 1991). 24: 3301-9. PMID 23901074 DOI: 10.1093/Cercor/Bht188  0.79
2014 Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, et al. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: e9-e18. PMID 23541187 DOI: 10.1016/J.Jalz.2013.01.007  0.328
2014 Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BN, Jagust WJ. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cerebral Cortex (New York, N.Y. : 1991). 24: 2210-8. PMID 23537530 DOI: 10.1093/Cercor/Bht076  0.752
2014 Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Molecular Psychiatry. 19: 351-7. PMID 23419831 DOI: 10.1038/Mp.2013.19  0.403
2014 Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cerebral Cortex (New York, N.Y. : 1991). 24: 1609-18. PMID 23389995 DOI: 10.1093/Cercor/Bht017  0.751
2014 Oh H, Habeck C, Madison C, Jagust W. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Human Brain Mapping. 35: 297-308. PMID 22965806 DOI: 10.1002/Hbm.22173  0.758
2014 Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Landau S, Luo J, Bauer R, Reschke C, Bandy D, Koeppe R, Fleisher AS, Caselli RJ, ... Jagust W, et al. Improving The Power To Track Fibrillar Amyloid Pet Measurements And Evaluate Amyloid-Modifying Treatments Using A Cerebral White Matter Reference Region-Of-Interest Alzheimers & Dementia. 10: 894. DOI: 10.1016/J.Jalz.2014.07.069  0.551
2014 Mattsson N, Insel P, Landau S, Jagust W, Shaw L, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. P2-094: COMPARING THE DIAGNOSTIC ACCURACIES OF CSF Aβ42 AND PET FLORBETAPIR Alzheimer's & Dementia. 10: P505-P505. DOI: 10.1016/J.Jalz.2014.05.768  0.612
2014 Ramanan VK, Nho K, Risacher SL, Kim S, Shen L, Swaminathan S, Foroud TM, Aisen P, Hakonarson H, Huentelman M, Jack C, Jagust W, Petersen RC, Potkin S, Shaw L, et al. P3-024: NEXT-GENERATION SEQUENCING OF THE BCHE LOCUS IDENTIFIES A FUNCTIONAL SNP ASSOCIATED WITH ALZHEIMER'S DISEASE BIOMARKERS AND AGE OF ONSET Alzheimer's & Dementia. 10: P636-P636. DOI: 10.1016/J.Jalz.2014.05.1111  0.386
2014 Risacher SL, Kim S, Nho KT, West JD, Wang Y, Petersen RC, Aisen PS, Jack CR, Jagust WJ, Koeppe R, Weiner MW, Saykin AJ. IC-P-096: INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS Alzheimer's & Dementia. 10: P54-P54. DOI: 10.1016/J.Jalz.2014.05.101  0.371
2014 Ghosh PM, Madison C, Santos M, Norton K, Baker S, Boxer AL, Rosen HJ, Miller ZA, Gorno-Tempini M, Miller BL, Jagust W, Rabinovici GD. IC-P-023: AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD Alzheimer's & Dementia. 10: P17-P18. DOI: 10.1016/J.Jalz.2014.05.027  0.38
2014 Rabinovici GD, Cohn-Sheehy BI, Reed B, Villeneuve S, Ghosh PM, Madison C, Lehmann M, Olichney J, DeCarli CS, Miller BL, Borys E, Grinberg LT, Jin L, Seeley WW, Jagust WJ. IC-P-011: COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES Alzheimer's & Dementia. 10: P12-P13. DOI: 10.1016/J.Jalz.2014.05.015  0.735
2014 Rabinovici GD, Ossenkoppele R, Perrotin A, Dore V, Jagust W, Bouwman FH, La Joie R, Villemagne VL, Miller B, Van der Flier WM, de La Sayette V, Masters CL, Scheltens P, van Berckel B, Rowe CC, et al. IC-P-010: CLINICALLY DIAGNOSED PROBABLE AD CASES WITH A NEGATIVE AMYLOID PET SCAN: CLINICAL FINDINGS Alzheimer's & Dementia. 10: P12-P12. DOI: 10.1016/J.Jalz.2014.05.014  0.366
2014 Chetelat G, Villemagne VL, Jagust W, Ossenkoppele R, Perrotin A, Dore V, Miller B, Flier WMvd, Joie RL, Ames D, Berckel Bv, Landeau B, Scheltens P, Mézenge F, Rowe CC, et al. Neurodegenerative And Cognitive Profile Of Patients With A Typical Phenotype Of Ad But With A Negative Amyloid Scan Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.013  0.429
2014 Lehmann M, Cohn-Sheehy BI, Pijnenburg Y, Seeley W, van Berckel B, Miller B, Lehmann M, Gorno-Tempini M, Kramer JH, van der Flier WM, Rosen H, Scheltens P, Jagust W, Barkhof F, Rabinovici GD. O5-01-05: COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P289-P289. DOI: 10.1016/J.Jalz.2014.04.480  0.735
2014 Mattsson N, Insel P, Landau S, Jagust W, Shaw L, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. O2-05-06: COMBINING CSF AB42 AND PET FLORBETAPIR TO PREDICT DIAGNOSIS, TAU, ATROPHY, AND COGNITION Alzheimer's & Dementia. 10: P174-P174. DOI: 10.1016/J.Jalz.2014.04.185  0.619
2014 Nosheny RL, Insel P, Mattsson N, Tosun D, Truran D, Schuff N, Jagust W, Petersen RC, Jack C, Aisen P, Weiner M. O1-07-03: EFFECTS OF AMYLOID STATUS AND AGE ON LONGITUDINAL REGIONAL BRAIN ATROPHY IN ELDERLY HEALTHY CONTROLS Alzheimer's & Dementia. 10: P142-P143. DOI: 10.1016/J.Jalz.2014.04.094  0.326
2014 Landau S, Fero A, Baker S, Jagust W. Modeling Longitudinal Florbetapir Change Across The Disease Spectrum Alzheimers & Dementia. 10: 7. DOI: 10.1016/J.Jalz.2014.04.031  0.551
2014 Villeneuve S, Madison C, Ayakta N, La Joie R, Cohn-Sheehy BI, Vogel J, Marks S, Arthur-Bentil SK, Reed B, DeCarli C, Rabinovici GD, Jagust W. IC-02-03: EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH Alzheimer's & Dementia. 10: P4-P5. DOI: 10.1016/J.Jalz.2014.04.026  0.726
2014 DeCarli C, Mungas D, Carmichael OT, Villeneuve S, Fletcher E, Singh B, Jagust W, Reed B. IC-01-04: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY Alzheimer's & Dementia. 10: P2-P3. DOI: 10.1016/J.Jalz.2014.04.021  0.524
2013 DeLuca AN, Heflin L, Fang S, Melisko ME, Moasser MM, Park JW, Chien AJ, Munster PN, Esserman L, Landau SM, Jagust WJ, Kramer JH. Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 104. PMID 28136629 DOI: 10.1200/Jco.2013.31.26_Suppl.104  0.59
2013 Fang S, DeLuca AN, Melisko ME, Moasser MM, Park JW, Chien AJ, Munster PN, Landau SM, Jagust WJ, Kramer JH, Rugo HS. Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 105. PMID 28136615 DOI: 10.1200/Jco.2013.31.15_Suppl.6619  0.591
2013 Oh H, Jagust WJ. Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18425-37. PMID 24259567 DOI: 10.1523/Jneurosci.2775-13.2013  0.725
2013 Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. Jama Neurology. 70: 1512-9. PMID 24166579 DOI: 10.1001/Jamaneurol.2013.4013  0.819
2013 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e111-94. PMID 23932184 DOI: 10.1016/j.jalz.2013.05.1769  0.349
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, ... ... Jagust WJ, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8  0.535
2013 Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, Gorno-Tempini ML, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 11606-11. PMID 23798398 DOI: 10.1073/Pnas.1221536110  0.339
2013 Haight TJ, Landau SM, Carmichael O, Schwarz C, DeCarli C, Jagust WJ. Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. Jama Neurology. 70: 1039-45. PMID 23779022 DOI: 10.1001/Jamaneurol.2013.1878  0.71
2013 Chao LL, Decarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack WJ, Chui HC, Weiner MW. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. Plos One. 8: e65175. PMID 23762308 DOI: 10.1371/Journal.Pone.0065175  0.519
2013 Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Archives of Neurology. 69: 940-1. PMID 23753644 DOI: 10.1001/archneurol.2012.510  0.555
2013 Landau S, Jagust W. Physical Activity and AD-Related Pathology-Reply. Archives of Neurology. 69: 940-1. PMID 23753644 DOI: 10.1001/archneurol.2012.510  0.555
2013 Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 10: 173-80. PMID 23702553 DOI: 10.1109/Tcbb.2012.141  0.33
2013 Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Frontiers in Aging Neuroscience. 5: 11. PMID 23554593 DOI: 10.3389/Fnagi.2013.00011  0.435
2013 Lo RY, Jagust WJ. Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Disease and Associated Disorders. 27: 343-50. PMID 23552443 DOI: 10.1097/WAD.0b013e3182900b2b  0.695
2013 Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid. Annals of Neurology. 74: 826-36. PMID 23536396 DOI: 10.1002/Ana.23908  0.658
2013 Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 5553-63. PMID 23536070 DOI: 10.1523/Jneurosci.4409-12.2013  0.819
2013 Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 687-698.e1. PMID 23474040 DOI: 10.1016/J.Jalz.2012.10.012  0.817
2013 Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. Jama Neurology. 70: 488-95. PMID 23400560 DOI: 10.1001/2013.Jamaneurol.405  0.573
2013 Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust WJ, Weiner MW, Jack CR. Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S116-23. PMID 23375568 DOI: 10.1016/J.Jalz.2012.10.011  0.443
2013 Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 677-86. PMID 23375562 DOI: 10.1016/J.Jalz.2012.09.016  0.459
2013 Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain : a Journal of Neurology. 136: 844-58. PMID 23358601 DOI: 10.1093/Brain/Aws327  0.406
2013 Mander BA, Rao V, Lu B, Saletin JM, Lindquist JR, Ancoli-Israel S, Jagust W, Walker MP. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nature Neuroscience. 16: 357-64. PMID 23354332 DOI: 10.1038/Nn.3324  0.804
2013 Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. The Lancet. Neurology. 12: 207-16. PMID 23332364 DOI: 10.1016/S1474-4422(12)70291-0  0.414
2013 Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 70-7. PMID 23166389 DOI: 10.2967/jnumed.112.109009  0.664
2013 Alkalay A, Rabinovici GD, Zimmerman G, Agarwal N, Kaufer D, Miller BL, Jagust WJ, Soreq H. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. Current Alzheimer Research. 10: 48-56. PMID 23157337 DOI: 10.2174/1567205011310010007  0.409
2013 Rabinovici G, Possin K, Cohn-Sheehy B, Ghosh P, Madison C, Hess C, Berger M, Kramer JH, Jagust W, Miller B. P4-380: Progressive memory loss with low amyloid burden in former professional American football players Alzheimer's & Dementia. 9: P875-P875. DOI: 10.1016/J.Jalz.2013.08.213  0.733
2013 Chen K, Stonnington C, Ayutyanont N, Reschke C, Thyyagura P, Protas H, Liu X, Roontiva A, Parks S, Bauer R, Lee W, Koeppe R, Jagust W, Foster N, Weiner M, et al. Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study Alzheimers & Dementia. 9: 844. DOI: 10.1016/J.Jalz.2013.08.007  0.408
2013 Wirth M, Haase CM, Villeneuve S, Madison C, Oh H, Jagust W. P2-131: Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults Alzheimer's & Dementia. 9: P393-P394. DOI: 10.1016/J.Jalz.2013.05.775  0.736
2013 Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging Alzheimers & Dementia. 9: 393. DOI: 10.1016/J.Jalz.2013.05.773  0.689
2013 Ossenkoppele R, Madison C, Oh H, Wirth M, Berckel Bv, Jagust W. Is verbal episodic memory in elderly individuals with amyloid deposits preserved through altered neuronal function Alzheimers & Dementia. 9: 392. DOI: 10.1016/J.Jalz.2013.05.771  0.695
2013 Lehmann M, Ghosh P, Madison C, Karydas A, Coppola G, Miller B, Jagust W, Rabinovici G. P1-272: Reduced amyloid deposition and greater hypometabolism in people with Alzheimer's disease who are APOE-ε4-positive Alzheimer's & Dementia. 9: P253-P253. DOI: 10.1016/J.Jalz.2013.05.497  0.397
2013 Nosheny R, Insel P, Truran D, Schuff N, Jack C, Aisen P, Petersen R, Jagust W, Shaw L, Trojanowski J, Weiner M. P1-158: The effect of age and amyloid status on hippocampal atrophy rate in normal controls and people with mild cognitive impairment in the ADNI cohort Alzheimer's & Dementia. 9: P207-P207. DOI: 10.1016/J.Jalz.2013.05.381  0.394
2013 Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging Alzheimers & Dementia. 9: 110. DOI: 10.1016/J.Jalz.2013.05.194  0.7
2013 Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau S, Madison C, Haense C, Herholz K, Reiman E, Jagust W, Frisoni G. Alzheimer's disease biomarkers as outcome measures for clinical trials Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1455  0.587
2013 Protas H, Chen K, Reschke C, Roontiva A, Liu X, Parks S, Lee W, Bauer R, Ayutyanont N, Thiyyagura P, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 68. DOI: 10.1016/J.Jalz.2013.05.109  0.43
2013 Risacher S, Petersen R, Aisen P, Jack C, Koeppe R, Jagust W, Farias ST, Mungas D, Trojanowski J, Shaw L, Weiner M, Saykin A. IC-P-105: Self-reported versus informant-based cognitive complaints: Relation of E-Cog scores to imaging biomarkers and clinical status in ADNI-2 Alzheimer's & Dementia. 9: P60-P62. DOI: 10.1016/J.Jalz.2013.05.102  0.308
2013 Cohn-Sheehy B, Ghosh P, Wirth M, Lehmann M, Madison C, Irwin W, Miller B, Jagust W, Rosen H, Rabinovici G. IC-P-069: Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease Alzheimer's & Dementia. 9: P41-P42. DOI: 10.1016/J.Jalz.2013.05.066  0.747
2013 Juan PS, Ghosh P, Hagen J, Gesierich B, Henry M, Gorno-Tempini M, Miller B, Jagust W, Rabinovici G. The practical utility of amyloid and FDG-PET in an academic dementia center Alzheimers & Dementia. 9: 22. DOI: 10.1016/J.Jalz.2013.05.024  0.384
2013 Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Haase CM, Marchant N, DeCarli CS, Chui H, Weiner M, Jagust W. IC-P-022: The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition Alzheimer's & Dementia. 9: P21-P22. DOI: 10.1016/J.Jalz.2013.05.023  0.33
2013 Haight T, Landau S, Jagust W. O5-02-05: Relationships among biomarkers in early-stage Alzheimer's disease (AD): Findings in cognitively normal adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's & Dementia. 9: P832-P832. DOI: 10.1016/J.Jalz.2013.04.479  0.655
2013 Oh H, Villeneuve S, Madison C, Vogel J, Jagust W. O4-09-05: Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging Alzheimer's & Dementia. 9: P701-P702. DOI: 10.1016/J.Jalz.2013.04.387  0.706
2013 Roontiva A, Chen K, Ayutyanont N, Protas H, Liu X, Thiyyagura P, Lee W, Reschke C, Parks S, Bauer R, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 698. DOI: 10.1016/J.Jalz.2013.04.377  0.443
2013 Jack C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P, Shaw L, Vemuri P, Wiste H, Weigand S, Lesnick T, Pankratz V, Donohue M, Trojanowski J. O3-03-01: Update on hypothetical model of Alzheimer's disease biomarkers Alzheimer's & Dementia. 9: P521-P522. DOI: 10.1016/J.Jalz.2013.04.248  0.333
2013 Lehmann M, Seeley W, Ghosh P, Madison C, Miller B, Grinberg L, Trojanowski J, Mendez M, Vinters H, Jagust W, Rabinovici G. O2-10-03: Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series Alzheimer's & Dementia. 9: P334-P335. DOI: 10.1016/J.Jalz.2013.04.191  0.363
2013 Lehmann M, Ghosh P, Madison C, Karydas A, Coppola G, Miller B, Jagust W, Rabinovici G. IC-O1-04: Reduced amyloid deposition and greater hypometabolism in APOE-ε4-positive Alzheimer's disease patients Alzheimer's & Dementia. 9: P4-P5. DOI: 10.1016/J.Jalz.2013.04.019  0.365
2012 Jagust WJ, Landau SM. Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 18227-33. PMID 23238736 DOI: 10.1523/JNEUROSCI.3266-12.2012  0.634
2012 Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology. 72: 578-86. PMID 23109153 DOI: 10.1002/Ana.23650  0.68
2012 Haight TJ, Jagust WJ. Relative contributions of biomarkers in Alzheimer's disease. Annals of Epidemiology. 22: 868-75. PMID 23102709 DOI: 10.1016/J.Annepidem.2012.09.004  0.416
2012 Toledo JB, Toledo E, Weiner MW, Jack CR, Jagust W, Lee VM, Shaw LM, Trojanowski JQ. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 483-9. PMID 23102118 DOI: 10.1016/J.Jalz.2011.08.008  0.412
2012 Cardenas VA, Reed B, Chao LL, Chui H, Sanossian N, DeCarli CC, Mack W, Kramer J, Hodis HN, Yan M, Buonocore MH, Carmichael O, Jagust WJ, Weiner MW. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke; a Journal of Cerebral Circulation. 43: 2865-70. PMID 22984010 DOI: 10.1161/Strokeaha.112.659722  0.496
2012 Lo RY, Jagust WJ. Vascular burden and Alzheimer disease pathologic progression. Neurology. 79: 1349-55. PMID 22972646 DOI: 10.1212/WNL.0b013e31826c1b9d  0.697
2012 Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Advances in Pharmacology (San Diego, Calif.). 64: 27-81. PMID 22840744 DOI: 10.1016/B978-0-12-394816-8.00002-7  0.432
2012 Dang LC, Donde A, Madison C, O'Neil JP, Jagust WJ. Striatal dopamine influences the default mode network to affect shifting between object features. Journal of Cognitive Neuroscience. 24: 1960-70. PMID 22640392 DOI: 10.1162/jocn_a_00252  0.307
2012 Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ. CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging and Behavior. 6: 599-609. PMID 22614327 DOI: 10.1007/S11682-012-9171-6  0.414
2012 Lo RY, Jagust WJ. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 78: 1376-82. PMID 22491869 DOI: 10.1212/Wnl.0B013E318253D5B3  0.694
2012 Oh H, Madison C, Haight TJ, Markley C, Jagust WJ. Effects of age and β-amyloid on cognitive changes in normal elderly people. Neurobiology of Aging. 33: 2746-55. PMID 22429886 DOI: 10.1016/J.Neurobiolaging.2012.02.008  0.736
2012 Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 592-600. PMID 22343502 DOI: 10.2967/Jnumed.111.094946  0.673
2012 Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Jagust W, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109  0.684
2012 Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Archives of Neurology. 69: 223-9. PMID 22332189 DOI: 10.1001/archneurol.2011.666  0.45
2012 Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ. Association of lifetime cognitive engagement and low β-amyloid deposition. Archives of Neurology. 69: 623-29. PMID 22271235 DOI: 10.1001/Archneurol.2011.2748  0.796
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  0.373
2012 Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiology of Aging. 33: 1979-87. PMID 22078485 DOI: 10.1016/j.neurobiolaging.2011.10.002  0.512
2012 Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust WJ. Cerebrovascular disease, β-amyloid, and cognition in aging. Neurobiology of Aging. 33: 1006.e25-36. PMID 22048124 DOI: 10.1016/J.Neurobiolaging.2011.10.001  0.567
2012 Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: S1-68. PMID 22047634 DOI: 10.1016/J.Jalz.2011.09.172  0.457
2012 Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cerebral Cortex (New York, N.Y. : 1991). 22: 1993-2004. PMID 22038908 DOI: 10.1093/Cercor/Bhr271  0.443
2012 Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cerebral Cortex (New York, N.Y. : 1991). 22: 1813-23. PMID 21945849 DOI: 10.1093/Cercor/Bhr255  0.337
2012 Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, et al. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging and Behavior. 6: 1-15. PMID 21901424 DOI: 10.1007/S11682-011-9136-1  0.421
2012 Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59: 1152-60. PMID 21884802 DOI: 10.1016/J.Neuroimage.2011.07.098  0.339
2012 Klostermann EC, Braskie MN, Landau SM, O'Neil JP, Jagust WJ. Dopamine and frontostriatal networks in cognitive aging. Neurobiology of Aging. 33: 623.e15-24. PMID 21511369 DOI: 10.1016/j.neurobiolaging.2011.03.002  0.72
2012 Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, Miller BL, Jagust WJ. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiology of Aging. 33: 215-25. PMID 20417582 DOI: 10.1016/J.Neurobiolaging.2010.03.011  0.438
2012 Rabinovici G, Jagust W, Ghosh P, Madison C, Karydas A, Boxer A, Trojanowski J, Miller B, Shaw L, Rosen H. Comparison of Amyloid PET and CSF Biomarkers in the Evaluation of Dementia (PD1.004) Neurology. 78: PD1.004-PD1.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Pd1.004  0.341
2012 Prestia A, Caroli A, Herholz K, Reiman E, Jagust W, Chen K, Frisoni G. Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.426  0.408
2012 Haight T, Jagust W. P1-023: Longitudinal relationships among biomarkers in Alzheimer's disease: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's & Dementia. 8: P115-P115. DOI: 10.1016/J.Jalz.2012.05.298  0.39
2012 Foster N, King R, Wang A, Landau S, Jagust W, Chen K, Reiman E. Discrepant diagnostic classification with AV45-PET and FDG-PET of clinically diagnosed Alzheimer's patients in the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.282  0.555
2012 Wirth M, Oh H, Mormino EC, Landau S, Jagust W. O1-10-02: Beta-amyloid deposition in normal elderly is related to longitudinal but not cross-sectional cognitive decline Alzheimer's & Dementia. 8: P102-P102. DOI: 10.1016/J.Jalz.2012.05.258  0.769
2012 Tosun D, Laforce R, Ghosh P, Madison C, Weiner M, Miller B, Jagust W, Rabinovici G. O4-09-05: Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology Alzheimer's & Dementia. 8: P632-P633. DOI: 10.1016/J.Jalz.2012.05.1687  0.36
2012 Lehmann M, Ghosh P, Madison C, Corbetta C, Long A, Miller B, Jagust W, Rabinovici G. O4-09-04: Diverging PIB and FDG covariance patterns across clinical variants of Alzheimer's disease Alzheimer's & Dementia. 8: P632-P632. DOI: 10.1016/J.Jalz.2012.05.1686  0.36
2012 Jagust W, Landau S. F4-01-04: Amyloid imaging in the multimodal evaluation of MCI Alzheimer's & Dementia. 8: P607-P608. DOI: 10.1016/j.jalz.2012.05.1628  0.555
2012 Risacher S, Kim S, Shen L, Ngo K, Foroud T, Petersen R, Aisen P, Jack C, Koeppe R, Jagust W, Weiner M, Saykin A. IC-P-098: The role of APOE-ɛ4 genotype in early mild cognitive impairment (EMCI): Preliminary results from ADNI-2 Alzheimer's & Dementia. 8: P56-P57. DOI: 10.1016/J.Jalz.2012.05.131  0.355
2012 Vossel KA, Beagle A, Hegde M, Mantle M, Kirsch H, Garcia P, Honma S, Findlay A, Rabinovici G, Jagust W, Nagarajan S, Miller B, Roberson E, Mucke L. P2-377: Subclinical epileptiform activity in Alzheimer's disease Alzheimer's & Dementia. 8: P395-P396. DOI: 10.1016/J.Jalz.2012.05.1087  0.357
2012 Protas H, Chen K, Reschke C, Roontiva A, Lee W, Nishimura M, Ayutyanont N, Liu X, Thiyyagura P, Parks S, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares Alzheimers & Dementia. 8: 20. DOI: 10.1016/J.Jalz.2012.05.056  0.365
2011 Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, ... ... Jagust WJ, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 77: 2034-42. PMID 22131541 DOI: 10.1212/Wnl.0B013E31823B9C5E  0.379
2011 Jagust WJ, Mormino EC. Lifespan brain activity, β-amyloid, and Alzheimer's disease. Trends in Cognitive Sciences. 15: 520-6. PMID 21983147 DOI: 10.1016/j.tics.2011.09.004  0.462
2011 Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, et al. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 514-20. PMID 21889115 DOI: 10.1016/J.Jalz.2010.12.010  0.51
2011 Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM, et al. Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathologica. 122: 401-13. PMID 21805181 DOI: 10.1007/S00401-011-0861-8  0.517
2011 Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ. Longitudinal change of biomarkers in cognitive decline. Archives of Neurology. 68: 1257-66. PMID 21670386 DOI: 10.1001/Archneurol.2011.123  0.694
2011 Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, ... Jagust WJ, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 76: 1789-96. PMID 21525424 DOI: 10.1212/Wnl.0B013E31821Cccad  0.433
2011 Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 270-9. PMID 21514249 DOI: 10.1016/j.jalz.2011.03.008  0.317
2011 Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain : a Journal of Neurology. 134: 1077-88. PMID 21429865 DOI: 10.1093/Brain/Awr044  0.424
2011 Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cerebral Cortex (New York, N.Y. : 1991). 21: 2399-407. PMID 21383234 DOI: 10.1093/Cercor/Bhr025  0.418
2011 Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR, Landau SM, Foster NL, ... ... Jagust WJ, et al. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 56: 52-60. PMID 21276856 DOI: 10.1016/J.Neuroimage.2011.01.049  0.699
2011 Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Archives of Neurology. 68: 329-37. PMID 21059987 DOI: 10.1001/Archneurol.2010.295  0.549
2011 Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ. β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 54: 1887-95. PMID 20965254 DOI: 10.1016/J.Neuroimage.2010.10.027  0.75
2011 Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust WJ. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Human Brain Mapping. 32: 947-61. PMID 20578173 DOI: 10.1002/Hbm.21081  0.743
2011 Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging. 32: 1207-18. PMID 19660834 DOI: 10.1016/J.Neurobiolaging.2009.07.002  0.673
2011 Landau SM, Jagust WJ. Reply from the authors Neurology. 76: 106. DOI: 10.1212/WNL.0b013e3181fe6f47  0.638
2011 Saykin A, Swaminathan S, Risacher S, Yoder K, West J, Shen L, Kim S, Inlow M, Foroud T, Jagust W, Koeppe R, Mathis C. P4-363: APOE e4 status modulates the association of plasma and cortical Aβ: Relation of plasma Aβ and [11C]PiB PET in the ADNI cohort Alzheimer's & Dementia. 7: e39-e39. DOI: 10.1016/J.Jalz.2011.09.177  0.332
2011 Reed B, Marchant N, Jagust W, Decarli C, Chui H. Coronary risk correlates with cerebral amyloid deposition in non demented elders Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.874  0.463
2011 Ayutyanont N, Chen K, Roontiva A, Fleisher A, Langbaum J, Reschke C, Lee W, Liu X, Bandy D, Alexander G, Foster N, Harvey D, Weiner M, Koeppe R, Jagust W, et al. Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.150  0.39
2011 Marchant N, Madison C, Martinez O, Carmichael O, DeCarli C, Reed B, Jagust W. Effects of MRI markers of cerebrovascular disease on amyloid burden and cognition in aging Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1224  0.557
2011 Landau S, Petersen R, Aisen P, Jagust W. IC-P-049: Change in amyloid deposition is related to concurrent cognitive change in MCI Alzheimer's & Dementia. 7: S28-S28. DOI: 10.1016/J.Jalz.2011.05.118  0.61
2010 Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, et al. Validation of consensus panel diagnosis in dementia. Archives of Neurology. 67: 1506-12. PMID 21149812 DOI: 10.1001/Archneurol.2010.301  0.316
2010 Wilcox CE, Braskie MN, Kluth JT, Jagust WJ. Overeating Behavior and Striatal Dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET. Journal of Obesity. 2010. PMID 20798859 DOI: 10.1155/2010/909348  0.632
2010 Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, ... ... Jagust WJ, et al. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192: 277-85. PMID 20678521 DOI: 10.1016/J.Jneumeth.2010.07.030  0.514
2010 Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR, Weiner MW, Jagust WJ. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 75: 230-8. PMID 20592257 DOI: 10.1212/Wnl.0B013E3181E8E8B8  0.687
2010 Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-303. PMID 20538372 DOI: 10.1016/J.Neurobiolaging.2010.05.003  0.464
2010 Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, et al. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 239-46. PMID 20451872 DOI: 10.1016/J.Jalz.2010.03.006  0.419
2010 Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, ... Jagust W, et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 230-8. PMID 20451871 DOI: 10.1016/J.Jalz.2010.03.008  0.438
2010 Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 221-9. PMID 20451870 DOI: 10.1016/J.Jalz.2010.03.003  0.648
2010 Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, et al. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 202-11.e7. PMID 20451868 DOI: 10.1016/J.Jalz.2010.03.007  0.478
2010 Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, et al. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 51: 654-64. PMID 20202480 DOI: 10.1016/J.Neuroimage.2010.02.064  0.54
2010 Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. The American Journal of Psychiatry. 167: 589-97. PMID 20160005 DOI: 10.1176/Appi.Ajp.2009.09020280  0.338
2010 Kuczynski B, Targan E, Madison C, Weiner M, Zhang Y, Reed B, Chui HC, Jagust W. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 54-62. PMID 20129319 DOI: 10.1016/J.Jalz.2009.04.1228  0.352
2010 Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet. Neurology. 9: 119-28. PMID 20083042 DOI: 10.1016/S1474-4422(09)70299-6  0.44
2010 Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain : a Journal of Neurology. 133: 512-28. PMID 20080878 DOI: 10.1093/Brain/Awp326  0.426
2010 Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 74: 201-9. PMID 20042704 DOI: 10.1212/Wnl.0B013E3181Cb3E25  0.417
2010 Tosun D, Schuff N, Jagust W, Weiner MW. O4-03-02: Relationship Between Regional Brain Amyloid-β Deposition and Brain Atrophy Rates in Mild Cognitive Impairment Alzheimer's & Dementia. 6: e15-e15. DOI: 10.1016/J.Jalz.2010.08.047  0.362
2010 Foster NL, Wang AY, Fletcher PT, Joshi S, Minoshima S, Jagust WJ, Chen K, Reiman EM, Weiner MW. Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 6: S298. DOI: 10.1016/J.Jalz.2010.05.976  0.381
2010 Chen K, Ayutyanont N, Langbaum J, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Yu M, Foster NL, Weiner MW, Thompson PM, Koeppe RA, Jagust WJ, et al. Use of an Alzheimer's Disease-Related Hypometabolic Convergence Index to Predict Progression from Mild Cognitive Impairment to Alzheimer's Dementia Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.971  0.526
2010 Landau SM, Harvey D, Reiman EM, Foster NL, Aisen PS, Trojanowski JQ, Shaw L, Jack CR, Petersen RC, Weiner MW, Jagust WJ. O3-03-08: Biomarker predictors of cognitive decline in healthy older participants in the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 6: S131-S131. DOI: 10.1016/J.Jalz.2010.05.411  0.64
2010 Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Knopman DS, Bernstein MA, Gunter JL, Aisen PS, Weiner MW, Petersen RC, Jagust WJ, Shaw LM, Trojanowski JQ. Brain Aβ amyloid measures and MRI are complimentary predictors of progression from MCI to Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.307  0.423
2010 Rabinovici GD, Alkalay A, Marchant NL, DeCarli C, Chui HC, Reed BR, Jagust WJ. IC-03-03: Amyloid and cerebrovascular disease both contribute to cognitive impairment in individuals with high vascular risk Alzheimer's & Dementia. 6: S59-S59. DOI: 10.1016/J.Jalz.2010.05.165  0.523
2010 Rabinovici GD, Alkalay A, Rosen HJ, Furst AJ, Agarwal N, O'Neil JP, Jang JY, Growdon ME, Yen IV, Madison C, Baker SL, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ. IC-P-132: Comparison of [11C]PIB and [18F]FDG PET in Discriminating Alzheimer's Disease and Frontotemporal Lobar Degeneration Alzheimer's & Dementia. 6: S52-S53. DOI: 10.1016/J.Jalz.2010.05.147  0.373
2009 Van Boven RW, Harrington GS, Hackney DB, Ebel A, Gauger G, Bremner JD, D'Esposito M, Detre JA, Haacke EM, Jack CR, Jagust WJ, Le Bihan D, Mathis CA, Mueller S, Mukherjee P, et al. Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. Journal of Rehabilitation Research and Development. 46: 717-57. PMID 20104401 DOI: 10.1682/Jrrd.2008.12.0161  0.459
2009 Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC, Weiner MW. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 454-62. PMID 19896584 DOI: 10.1016/J.Jalz.2009.04.1233  0.389
2009 Rabinovici GD, Jagust WJ. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behavioural Neurology. 21: 117-28. PMID 19847050 DOI: 10.3233/BEN-2009-0232  0.368
2009 Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA. Relationships between biomarkers in aging and dementia. Neurology. 73: 1193-9. PMID 19822868 DOI: 10.1212/Wnl.0B013E3181Bc010C  0.672
2009 Barnes DE, Yaffe K, Belfor N, Jagust WJ, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Disease and Associated Disorders. 23: 205-10. PMID 19812460 DOI: 10.1097/Wad.0B013E31819C6137  0.485
2009 Haense C, Herholz K, Jagust WJ, Heiss WD. Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dementia and Geriatric Cognitive Disorders. 28: 259-66. PMID 19786778 DOI: 10.1159/000241879  0.415
2009 Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 45: 1107-16. PMID 19349228 DOI: 10.1016/J.Neuroimage.2008.12.072  0.46
2009 Kuczynski B, Jagust W, Chui HC, Reed BR. An inverse association of cardiovascular risk and frontal lobe glucose metabolism Neurology. 72: 738-743. PMID 19237703 DOI: 10.1212/01.Wnl.0000343005.35498.E5  0.384
2009 Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1538-43. PMID 19193900 DOI: 10.1523/JNEUROSCI.4467-08.2009  0.692
2009 Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320  0.433
2009 Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cerebral Cortex (New York, N.Y. : 1991). 19: 445-54. PMID 18550595 DOI: 10.1093/Cercor/Bhn095  0.581
2009 Landau SM, Harvey D, Madison C, Foster NL, Reiman EM, Shaw LM, Trojanowski JQ, Petersen RC, Weiner MW, Jagust WJ. O3-01-01: Comparing predictors of conversion: Data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 5: P125-P125. DOI: 10.1016/J.Jalz.2009.05.421  0.602
2008 Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust WJ. Relationship of striatal dopamine synthesis capacity to age and cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14320-8. PMID 19109513 DOI: 10.1523/Jneurosci.3729-08.2008  0.747
2008 DeCarli C, Reed BR, Jagust W, Martinez O, Ortega M, Mungas D. Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Disease and Associated Disorders. 22: 382-91. PMID 19068502 DOI: 10.1097/WAD.0b013e318185e7fe  0.512
2008 Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Annals of Neurology. 64: 388-401. PMID 18991338 DOI: 10.1002/Ana.21451  0.417
2008 Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 22: 531-44. PMID 18590364 DOI: 10.1037/0894-4105.22.4.531  0.518
2008 Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Archives of Neurology. 65: 650-5. PMID 18474742 DOI: 10.1001/Archneur.65.5.650  0.456
2008 Garrod MG, Green R, Allen LH, Mungas DM, Jagust WJ, Haan MN, Miller JW. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clinical Chemistry. 54: 1210-7. PMID 18451312 DOI: 10.1373/Clinchem.2007.102632  0.313
2008 Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. International Journal of Geriatric Psychiatry. 23: 1040-50. PMID 18412291 DOI: 10.1002/Gps.2030  0.364
2008 Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 1208-12. PMID 18234898 DOI: 10.1523/JNEUROSCI.4475-07.2008  0.71
2008 Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC. Neuropathological basis of magnetic resonance images in aging and dementia. Annals of Neurology. 63: 72-80. PMID 18157909 DOI: 10.1002/Ana.21296  0.583
2008 Haan MN, Aiello AE, West NA, Jagust WJ. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype. Neurobiology of Aging. 29: 1774-82. PMID 17540481 DOI: 10.1016/J.Neurobiolaging.2007.04.020  0.414
2008 Chen K, Lee W, Liu X, Alexander G, Bandy D, Reschke C, Foster N, Weiner M, Koeppe R, Jagust W, Reiman E. P1-338: The consistency of hypometabolic brain voxels in probable Alzheimer's disease and amnestic mild cognitive impairment patients from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T318-T318. DOI: 10.1016/J.Jalz.2008.05.919  0.436
2008 Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. P1-312: Differentiating amnestic mild cognitive impairment converting to probable Alzheimer's disease from stable amnestic mild cognitive impairment using FDG-PET and an Alzheimer's disease-related hypometabolism overlap index Alzheimer's & Dementia. 4: T312-T312. DOI: 10.1016/J.Jalz.2008.05.903  0.449
2008 Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. P1-280: Amyloid and glucose metabolism in early versus late-onset Alzheimer's disease: A comparative [11C]PIBand [18F]FDG PET study Alzheimer's & Dementia. 4: T299-T299. DOI: 10.1016/J.Jalz.2008.05.870  0.382
2008 Landau SM, Madison C, Wu D, Cheung C, Foster N, Reiman E, Koeppe R, Weiner M, Jagust WJ. P1-258: Pinpointing change in Alzheimer's disease: Longitudinal FDG-PET analyses from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T291-T292. DOI: 10.1016/J.Jalz.2008.05.848  0.643
2008 Madison C, Landau S, Cheung C, Lal R, Foster N, Reiman E, Koeppe R, Weiner M, Jagust W. IC-P2-114: Meta-analysis ROIs and minimal deformation templates improve PET-FDG as a candidate biomarker in Alzheimer's disease Alzheimer's & Dementia. 4: T53-T53. DOI: 10.1016/J.Jalz.2008.05.2569  0.647
2008 Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. IC-01-06: Amyloid and glucose metabolism in early versus late-onset AD: A comparative [11C]PIB and [18F]FDG PET study Alzheimer's & Dementia. 4: T4-T4. DOI: 10.1016/J.Jalz.2008.05.2492  0.372
2008 Reiman EM, Chen K, Ayutyanont N, Lee W, Bandy D, Reschke C, Alexander GE, Weiner MW, Koeppe RA, Foster NL, Jagust WJ. O1-02-06: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI) Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.225  0.336
2008 Reed B, Mungas D, Kramer JH, Ellis W, Vinters HV, Zarow C, DeCarli C, Jagust WJ, Chui HC. P3-173: Verbal list learning in cases with Alzheimer's disease, vascular, and mixed neuropathology Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1739  0.492
2008 Chen K, Reschke C, Lee W, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P2-086: The pattern of cerebral hypometablism in amnestic mild cognitive impairment and its relationship to subsequent conversion to probable Alzheimer's disease: Preliminary findings from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.079  0.424
2008 Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. IC-P2-074: Differentiating amnestic MCI converting to probable AD from stable amnestic MCI using FDG-PET and an AD-related hypometabolism overlap index Alzheimer's & Dementia. 4: T38-T38. DOI: 10.1016/J.Jalz.2008.05.067  0.404
2008 Lee W, Langbaum JBS, Chen K, Recshke C, Bandy D, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P1-036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.047  0.371
2008 Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Alzheimer's Disease Neuroimaging Initiative Neuroimage. 45: 183-189. DOI: 10.1007/978-0-387-72076-0_18  0.377
2007 Eberling JL, Bankiewicz KS, O'Neil JP, Jagust WJ. PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates. Frontiers in Human Neuroscience. 1: 9. PMID 18958223 DOI: 10.3389/neuro.09.009.2007  0.332
2007 Jagust W, Reed BR, Mungas DM, Ellis W, DeCarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia Neurology. 69: 871-877. PMID 17724289 DOI: 10.1212/01.Wnl.0000269790.05105.16  0.566
2007 Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a Journal of Neurology. 130: 2616-35. PMID 17704526 DOI: 10.1093/Brain/Awm177  0.544
2007 Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 69: 283-90. PMID 17636066 DOI: 10.1212/01.Wnl.0000265815.38958.B6  0.425
2007 Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 68: 1205-12. PMID 17420404 DOI: 10.1212/01.Wnl.0000259035.98480.Ed  0.428
2007 Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. The American Journal of Clinical Nutrition. 85: 511-7. PMID 17284751 DOI: 10.1093/Ajcn/85.2.511  0.348
2007 Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain : a Journal of Neurology. 130: 731-9. PMID 17267522 DOI: 10.1093/Brain/Awl385  0.432
2007 Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology. 68: 13-9. PMID 17200485 DOI: 10.1212/01.Wnl.0000250326.77323.01  0.412
2007 Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust WJ. Automated template-based PET region of interest analyses in the aging brain. Neuroimage. 34: 608-17. PMID 17112749 DOI: 10.1016/j.neuroimage.2006.09.022  0.655
2007 Garrod MG, Green R, Allen LH, Mungas DM, Jagust WJ, Haan MN, Miller JW. The ratio of holotranscobalamin to total B12 is associated with cognitive impairment in elderly Latinos with elevated depression scores The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A155  0.312
2007 Chen K, Reiman EM, Alexander GE, Smilovici O, Lee W, Reschke C, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ. P-024: The pattern and severity of FDG pet abnormalities in Alzheimer’s disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer’s disease neuroimaging initiative Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.240  0.416
2007 Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust WJ, Trojanowski JQ, Shaw LM, Toga AW, Beckett LA, Gamst AC. O1-04-04: The Alzheimer's disease neuroimaging initiative: Progress report Alzheimer's & Dementia. 3: S174-S174. DOI: 10.1016/J.Jalz.2007.04.080  0.344
2006 Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Annals of Neurology. 60: 677-87. PMID 17192928 DOI: 10.1002/Ana.21009  0.575
2006 Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust WJ, Weiner MW. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Disease and Associated Disorders. 20: 77-85. PMID 16772742 DOI: 10.1097/01.Wad.0000213809.12553.Fc  0.391
2006 Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ. White matter changes compromise prefrontal cortex function in healthy elderly individuals. Journal of Cognitive Neuroscience. 18: 418-29. PMID 16513006 DOI: 10.1162/089892906775990552  0.776
2006 Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging Annals of Neurology. 59: 673-681. PMID 16470518 DOI: 10.1002/Ana.20799  0.718
2006 Lopez OL, Becker JT, Jagust WJ, Fitzpatrick A, Carlson MC, DeKosky ST, Breitner J, Lyketsos CG, Jones B, Kawas C, Kuller LH. Neuropsychological characteristics of mild cognitive impairment subgroups. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 159-65. PMID 16103044 DOI: 10.1136/Jnnp.2004.045567  0.373
2006 Du AT, Schuff N, Chao LL, Kornak J, Jagust WJ, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiology of Aging. 27: 733-40. PMID 15961190 DOI: 10.1016/J.Neurobiolaging.2005.03.021  0.37
2006 Ranasinghe KG, Cha J, Hinkley LB, Beagle AJ, Mizuiri D, Honma S, Bourakova V, Jagust WJ, Miller BL, Rabinovici GD, Nagarajan SS, Vossel KA. O1-01-05: DISTINCT NEURAL OSCILLATION ABNORMALITIES ASSOCIATED WITH AMYLOID-BETA AND TAU IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P213-P214. DOI: 10.1016/J.Jalz.2018.06.2334  0.362
2006 La Joie R, Visani A, Lesman-Segev OH, Bourakova V, Baker SL, Janabi M, Miller ZA, O'Neil JP, Perry D, Pham J, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. IC-P-145: NON-AMNESTIC PHENOTYPES OF ALZHEIMER'S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT Aβ-PET Alzheimer's & Dementia. 14: P123-P124. DOI: 10.1016/J.Jalz.2018.06.2211  0.426
2006 Cha J, Park Y, Lee J, Baker SL, Visani A, Bourakova V, Pham J, Janabi M, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-136: MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER'S DISEASE SPECTRUM: CROSS-SECTIONAL STUDY Alzheimer's & Dementia. 14: P113-P115. DOI: 10.1016/J.Jalz.2018.06.2202  0.356
2006 Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. IC-P-131: HUMAN IN VIVO TAU PATHOLOGY, IMPAIRED NREM SLEEP OSCILLATIONS AND MEMORY DECLINE IN AGING Alzheimer's & Dementia. 14: P108-P109. DOI: 10.1016/J.Jalz.2018.06.2197  0.796
2006 Protas H, Ghisays V, Luo J, DeMarco EL, Thiyyagura P, Devadas V, Bauer R, Landau SM, Weiner M, Jagust WJ, Reiman EM, Chen K. IC-P-106: FLORTAUCIPIR PAIRED HELICAL FILAMENT TAU BURDEN AND CORRELATION WITH COGNITIVE DECLINE IN MCI PATIENTS WITHOUT Aβ Alzheimer's & Dementia. 14: P91-P92. DOI: 10.1016/J.Jalz.2018.06.2172  0.632
2006 Landau SM, Korman D, Jagust WJ. IC-02-02: DISCREPANCIES IN TAU AND β-AMYLOID BURDEN ARE FREQUENT ACROSS THE SPECTRUM OF NORMAL AGING AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P2-P3. DOI: 10.1016/j.jalz.2018.06.2045  0.555
2006 Brown J, La Joie R, Visani A, Rosen HJ, Miller BL, Jagust WJ, Seeley WW, Rabinovici GD. P3-415: PATIENT-TAILORED PREDICTIONS OF GRAY MATTER ATROPHY IN ALZHEIMER'S DISEASE BASED ON BASELINE FLORTAUCIPIR AND CONNECTOME-BASED SPREAD Alzheimer's & Dementia. 14: P1265-P1266. DOI: 10.1016/J.Jalz.2018.06.1778  0.352
2006 Weiner MW, Zhang Y, Jahng G, Whitney B, Mori S, Schad L, Mueller S, Du A, Kramer J, Yaffe K, Chui HL, Jagust WJ, Miller BL, Schuff N. IC-P-114: Improved classification of MCI and Alzheimer's disease using diffusion tensor imaging of cingulum white matter Alzheimer's & Dementia. 2: S697-S698. DOI: 10.1016/J.Jalz.2006.05.2320  0.328
2006 Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Beckett LA. IC-P-104: Imaging biomarkers to monitor treatment effects for Alzheimer's disease trials: The Alzheimer's disease imaging initiative Alzheimer's & Dementia. 2: S694-S694. DOI: 10.1016/J.Jalz.2006.05.2310  0.349
2006 Barnes DE, Yaffe K, Belfor N, Reed B, Jagust W, DeCarli C, Kramer J. P3-451: Computer-based cognitive therapy for mild cognitive impairment: Results of a pilot randomized, controlled trial Alzheimer's & Dementia. 2: S508-S509. DOI: 10.1016/J.Jalz.2006.05.1722  0.493
2006 Haan MN, Jagust WJ, Miller JW, Aiello AA, Mungas DM, Allen LH, Green RR. O2-06-05: Homocysteine and incidence of dementia and cognitive impairment in older Mexican Americans: Results from the sacramento area latino study on aging Alzheimer's & Dementia. 2: S43-S43. DOI: 10.1016/J.Jalz.2006.05.151  0.365
2006 Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Beckett LA. P2-254: Imaging biomarkers to monitor treatment effects for Alzheimer's disease trials: The Alzheimer's disease imaging initiative Alzheimer's & Dementia. 2: S311-S311. DOI: 10.1016/J.Jalz.2006.05.1093  0.354
2006 Jagust W, Mormino B, DeCarli C, Kramer J, Barnes D, Reed B. P2-185: Metabolic and cognitive changes with computer based cognitive therapy for MCI Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1023  0.5
2006 Weiner MW, Zhang Y, Jahng G, Bayne W, Mori S, Schad L, Mueller S, Du A, Kramer J, Yaffe K, Chui HL, Jagust WJ, Miller BL, Schuff N. O1-03-05: Improved classification of MCI and Alzheimer's disease using diffusion tensor imaging of cingulum white matter Alzheimer's & Dementia. 2: S13-S14. DOI: 10.1016/J.Jalz.2006.05.048  0.324
2005 Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 55-66. PMID 17476317 DOI: 10.1016/J.Jalz.2005.06.003  0.397
2005 Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clinics of North America. 15: 869-77, xi-xii. PMID 16443497 DOI: 10.1016/J.Nic.2005.09.008  0.382
2005 Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN, Green R, Miller JW. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. The American Journal of Clinical Nutrition. 82: 1346-52. PMID 16332669 DOI: 10.1093/Ajcn/82.6.1346  0.386
2005 Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Archives of Neurology. 62: 1545-8. PMID 16216937 DOI: 10.1001/Archneur.62.10.1545  0.327
2005 Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 65: 565-71. PMID 16116117 DOI: 10.1212/01.Wnl.0000172913.88973.0D  0.558
2005 Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. Journal of the American Geriatrics Society. 53: 1101-7. PMID 16108925 DOI: 10.1111/J.1532-5415.2005.53360.X  0.351
2005 Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 65: 397-403. PMID 16087904 DOI: 10.1212/01.Wnl.0000171343.43314.6E  0.566
2005 Nordahl CW, Ranganath C, Yonelinas AP, DeCarli C, Reed BR, Jagust WJ. Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia. 43: 1688-97. PMID 16009250 DOI: 10.1016/J.Neuropsychologia.2005.01.003  0.79
2005 Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 64: 1548-52. PMID 15883315 DOI: 10.1212/01.Wnl.0000160115.55756.De  0.393
2005 Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Kawas C, Carlson M. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 64: 1539-47. PMID 15883314 DOI: 10.1212/01.Wnl.0000159860.19413.C4  0.406
2005 Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. Journal of the Neurological Sciences. 229: 43-9. PMID 15760618 DOI: 10.1016/J.Jns.2004.11.022  0.41
2005 Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 234: 851-9. PMID 15734937 DOI: 10.1148/Radiol.2343040197  0.404
2005 Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust WJ, Chui HC, Miller BL, Yaffe K, Weiner MW. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology. 64: 282-9. PMID 15668426 DOI: 10.1212/01.Wnl.0000149638.45635.Ff  0.417
2005 Du AT, Schuff N, Chao LL, Kornak J, Ezekiel F, Jagust WJ, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiology of Aging. 26: 553-9. PMID 15653183 DOI: 10.1016/J.Neurobiolaging.2004.05.002  0.402
2005 DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke; a Journal of Cerebral Circulation. 36: 50-5. PMID 15576652 DOI: 10.1161/01.Str.0000150668.58689.F2  0.45
2005 DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 63: 220-7. PMID 15277612 DOI: 10.1212/01.Wnl.0000130531.90205.Ef  0.455
2004 Reed BR, Mungas DM, Kramer JH, Betz BP, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC. Clinical and neuropsychological features in autopsy-defined vascular dementia. The Clinical Neuropsychologist. 18: 63-74. PMID 15595359 DOI: 10.1080/13854040490507163  0.432
2004 Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function. Archives of Neurology. 61: 1545-50. PMID 15477508 DOI: 10.1001/Archneur.61.10.1545  0.377
2004 Kramer JH, Schuff N, Reed BR, Mungas D, Du AT, Rosen HJ, Jagust WJ, Miller BL, Weiner MW, Chui HC. Hippocampal volume and retention in Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 10: 639-43. PMID 15327742 DOI: 10.1017/S1355617704104050  0.358
2004 Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ. White matter lesions impair frontal lobe function regardless of their location. Neurology. 63: 246-53. PMID 15277616 DOI: 10.1212/01.WNL.0000130530.55104.B5  0.381
2004 Petkov CI, Wu CC, Eberling JL, Mungas D, Zrelak PA, Yonelinas AP, Haan MN, Jagust WJ. Correlates of memory function in community-dwelling elderly: the importance of white matter hyperintensities. Journal of the International Neuropsychological Society : Jins. 10: 371-81. PMID 15147595 DOI: 10.1017/S1355617704103056  0.372
2004 Farias ST, Mungas D, Reed B, Haan MN, Jagust WJ. Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults. Journal of the International Neuropsychological Society : Jins. 10: 342-54. PMID 15147592 DOI: 10.1017/S1355617704103020  0.362
2004 Maltz JS, Eberling JL, Jagust WJ, Budinger TF. Enhanced cutaneous vascular response in AD subjects under donepezil therapy. Neurobiology of Aging. 25: 475-81. PMID 15013568 DOI: 10.1016/S0197-4580(03)00124-6  0.593
2004 Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust WJ, Miller BL, Reed BR, Mungas D, Yaffe K, Chui HC, Weiner MW. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology. 62: 422-7. PMID 14872024 DOI: 10.1212/01.Wnl.0000106462.72282.90  0.402
2004 Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C. Incidence and prevalence of dementia in the Cardiovascular Health Study. Journal of the American Geriatrics Society. 52: 195-204. PMID 14728627 DOI: 10.1111/J.1532-5415.2004.52058.X  0.352
2004 Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Statistics in Medicine. 23: 315-26. PMID 14716732 DOI: 10.1002/Sim.1719  0.548
2004 Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study Neurobiology of Aging. 25: S483-S484. DOI: 10.1016/S0197-4580(04)81597-5  0.341
2004 Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Kawas C, Carlson M. P4-038 Classification of vascular dementia in the cardiovascular health study cognition study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81596-3  0.335
2004 Miller JW, Ramos MI, Green R, Mungas DM, Jagust WJ, Allen LH, Haan MN. P3-107 Folate, independent of homocysteine, is inversely associated with cognitive function and dementia in latino elderly: a report from the sacramento area latino study on aging (SALSA) Neurobiology of Aging. 25: S385. DOI: 10.1016/S0197-4580(04)81259-4  0.378
2004 Du A, Schuff N, Chao LL, Jagust WJ, Kramer JH, Reed BR, Miller BL, Chui HC, Weiner MW. P3-094 Predicting cognitive decline with baseline hippocampal volume and rate of hippocampal atrophy Neurobiology of Aging. 25: S380. DOI: 10.1016/S0197-4580(04)81246-6  0.334
2004 Foster NL, Barbas NR, Heidebrink JL, Scott Turner R, Clark CM, Jagust WJ, Arnold SE, DeCarli CS, Koeppe RA, Higdon R. P3-070 Adding FDG-PET to clinical history and examination improves the accuracy of dementia diagnosis Neurobiology of Aging. 25: S372. DOI: 10.1016/S0197-4580(04)81222-3  0.392
2004 Heidebrink JL, Barbas NR, Scott Turner R, Clark CM, Jagust WJ, Arnold SE, DeCarli CS, Koeppe RA, Higdon R, Foster NL. P3-065 FDG-PET improves differential diagnosis of dementia when clinical history and examination are ambiguous Neurobiology of Aging. 25: S370-S371. DOI: 10.1016/S0197-4580(04)81217-X  0.342
2004 Chao LL, Schuff N, Jagust WJ, Reed BR, Chui HC, Miller BL, Kramer JH, Du A, Weiner MW. P2-213 Selective reduction of medial temporal lobe NAA in cognitively impaired but non-demented elderly subjects Neurobiology of Aging. 25: S291. DOI: 10.1016/S0197-4580(04)80959-X  0.348
2004 Du A, Schuff N, Chao LI, Jagust WJ, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW. P2-198 Effects of age, cerebrovascular disease and APOE ε4 on entorhinal and hippocampal atrophy rates Neurobiology of Aging. 25: S285. DOI: 10.1016/S0197-4580(04)80944-8  0.325
2004 Johnson NA, Jahng G, Weiner MW, Chui HC, Miller B, Jagust WJ, Schuff N. P2-167 Patterns of cerebral hypoperfusion in Alzheimer's disease and mild cognitive impairment measured with arterial spin labeled MRI Neurobiology of Aging. 25: S273. DOI: 10.1016/S0197-4580(04)80914-X  0.374
2003 Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Archives of Neurology. 60: 1394-9. PMID 14568809 DOI: 10.1001/Archneur.60.10.1394  0.378
2003 Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of Neurology. 60: 1385-9. PMID 14568808 DOI: 10.1001/Archneur.60.10.1385  0.363
2003 Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust WJ, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology. 61: 358-64. PMID 12913198 DOI: 10.1212/01.Wnl.0000078942.63360.22  0.404
2003 Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust WJ, Chui HC, Schuff N, Weiner MW. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiology of Aging. 24: 537-44. PMID 12714110 DOI: 10.1016/S0197-4580(02)00130-6  0.347
2003 Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 246-9. PMID 12611755  0.391
2003 Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, Weiner MW. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology. 60: 481-6. PMID 12578931 DOI: 10.1212/01.Wnl.0000044400.11317.Ec  0.39
2003 Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. Journal of the American Geriatrics Society. 51: 169-77. PMID 12558712 DOI: 10.1046/J.1532-5415.2003.51054.X  0.332
2002 Wu CC, Mungas D, Eberling JL, Reed BR, Jagust WJ. Imaging Interactions between Alzheimer's disease and cerebrovascular disease. Annals of the New York Academy of Sciences. 977: 403-10. PMID 12480779 DOI: 10.1111/J.1749-6632.2002.Tb04844.X  0.425
2002 Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 59: 867-73. PMID 12297568 DOI: 10.1212/Wnl.59.6.867  0.565
2002 Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, Brunberg JA, Haan MN, Jagust WJ. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 59: 383-91. PMID 12177372 DOI: 10.1212/Wnl.59.3.383  0.378
2002 Jagust WJ, Eberling JL, Wu CC, Finkbeiner A, Mungas D, Valk PE, Haan MN. Brain function and cognition in a community sample of elderly Latinos. Neurology. 59: 378-83. PMID 12177371  0.306
2002 Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology. 58: 1635-41. PMID 12058091 DOI: 10.1212/Wnl.58.11.1635  0.408
2002 Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 58: 1608-15. PMID 12058087 DOI: 10.1212/Wnl.58.11.1608  0.329
2002 Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust WJ, Weiner MW. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Disease and Associated Disorders. 16: 58-64. PMID 12040300 DOI: 10.1097/00002093-200204000-00002  0.404
2002 Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology. 58: 1471-5. PMID 12034781 DOI: 10.1212/Wnl.58.10.1471  0.347
2002 Haan MN, Jagust WJ, Galasko D, Kaye J. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Archives of Neurology. 59: 588-93. PMID 11939893 DOI: 10.1001/Archneur.59.4.588  0.399
2002 Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 58: 928-35. PMID 11914410 DOI: 10.1212/Wnl.58.6.928  0.374
2001 Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust WJ, Reed BR. Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. Journal of Experimental Psychology. General. 130: 746-63. PMID 11757878 DOI: 10.1037//0096-3445.130.4.746  0.353
2001 Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology. 57: 2229-35. PMID 11756602 DOI: 10.1212/Wnl.57.12.2229  0.409
2001 Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. Jama. 286: 2120-7. PMID 11694153 DOI: 10.1001/Jama.286.17.2120  0.451
2001 Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 71: 441-7. PMID 11561025 DOI: 10.1136/Jnnp.71.4.441  0.431
2001 Mungas D, Reed BR, Ellis WG, Jagust WJ. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Archives of Neurology. 58: 1243-7. PMID 11493164 DOI: 10.1001/Archneur.58.8.1243  0.412
2001 Jagust W, Thisted R, Devous MD, Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology. 56: 950-6. PMID 11294935 DOI: 10.1212/Wnl.56.7.950  0.348
Show low-probability matches.